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Abstract 
 
Mucus is a hydrogel that covers epithelial cells and acts as an intermediary between the exterior and 
interior surfaces of the human body. It is complex and diverse, comprised of various compounds and 
serves as a selective barrier to pathogens, nutrients and administered substances. It is therefore 
important to circumvent or penetrate this barrier to increase drug bioavailability. The most important 
constituent of mucus is mucin glycoprotein that enables gel formation. Due to the molecular nature of 
mucin, it interacts with most substances including polyanionic biopolymers like alginates. Alginate 
molecules have been extensively used in pharmaceutical and medical industries as mediators because 
they possess suitable characteristics for a variety of biomedical applications. They have also been 
shown to influence mucus rheology, and could hold potential to alter other properties of mucus as 
well, such as particle mobility. In this thesis, the effect of different molecular weight alginates were 
investigated on the rheology of porcine gastric (PG) mucin, porcine small intestinal mucus (PSIM), 
porcine tracheobronchial mucus (PTBM) and bio-similar mucus. In addition, the effect of alginate on 
particle mobility in PG mucin samples were investigated using multiple particle tracking (MPT). The 
rheological effect of alginate G-block DPn 12, DPn 24, DPn 33 and alginate LFR 5/60 on PG mucin was 
inconclusive as the sample suffered from pH and mechanical instabilities. Particle mobility was greatest 
for G-block DPn 12 and G-block DPn 33 treated PG mucin at long time scales. In addition, their mean-
square displacement (MSD) trajectories were more narrowly distributed than the other samples, which 
correlates to a higher degree of uniform pore sizes. The rheological behaviour of bio-similar mucus and 
PSIM after treatment of G-block DPn 12, G-block DPn 33 and LFR 5/60 did not coincide, despite bio-
similar mucus being a model system for porcine intestinal mucus (PIM). This was ascribed interactions 
between alginate and polyacrylate in the bio-similar mucus causing phase separation. Alginate G-block 
DPn 12 weakened the PSIM and PTBM gel, while G-block DPn 33 and LFR 5/60 had minor strengthening 
effects on PSIM. 
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Sammendrag 
 
Mucus er en vannholdig gel som dekker epitelceller og fungerer som et skille mellom indre og ytre 
overflater i menneskekroppen. Slimlaget er en særdeles kompleks løsning bestående av mange 
forskjellige komponenter og virker som en selektiv barriere. Det beskytter kroppen mot potensielle 
patogener, men også administrerte medisiner. Det er derfor viktig å kartlegge måter å trenge gjennom 
mucus på slik at biotilgjengeligheten av medisiner øker. Den viktigste bestanddelen av mucus er mucin 
glykoproteiner som muliggjør gel dannelse. Den kjemiske diversiteten til muciner gjør at de kan 
vekselvirke med de fleste stoffer, inkludert polyanione biopolymerer slik som alginat. Alginatmolekyler 
har vært mye brukt i farmaindustrien på grunn av flere ønskelige karakteristikker som gjør dem 
interessante i medisinsk sammenheng. De har også blitt vist å påvirke reologien til mucus, som kan 
indikere et potensiale til å endre andre egenskaper ved mucus også, slik som partikkelmobilitet. I 
denne masteroppgaven har effekten av alginat med forskjellige kjedelengder blitt undersøkt på 
reologien til renset mucin fra grisemage (PG mucin), tynntarmslim fra gris (PSIM), tracheobronchialt 
slim fra gris (PTBM) og biolignende slim. I tillegg har effekten av alginat blitt undersøkt på 
partikkelmobilitet i PG mucin prøver ved hjelp av multiple particle tracking (MPT). Den reologiske 
effekten av G-blokk DPn 12, DPn 24, DPn 33 og alginat LFR 5/60 på PG mucin var resultatløst på grunn 
av dårlig pH og mekanisk stabilitet. Partikkelmobilitet var høyest for G-blokk DPn 12 og G-blokk DPn 33 
behandlet PG mucin ved lengre tidsskala. I tillegg hadde de smalere distribusjon av mean-square 
displacement (MSD) baner som tyder på at porestørrelsene i prøven ble mer uniform ved tilsats av 
alginat. Den reologiske adferden til biolignende slim og PSIM ved behandling av G-blokk DPn 12, G-
blokk DPn 33 og LFR 5/60 var ulik, selv om det biolignende slimet er laget som et modellsystem for 
tarmslim. Dette tilskrives interaksjoner mellom alginat og polyakrylsyre i det biolignende slimet som 
fører til faseseparasjon. Alginat G-blokk DPn 12 svekket gelstyrken til både PSIM og PTBM, mens G-
blokk DPn 33 og LFR 5/60 styrket gelen til PSIM noe. 
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Abbreviations 
 
Abbreviation Meaning 
<Deff> Ensemble effective diffusivity 
δ Phase angle 
ΔGmix Difference in Gibbs free energy upon mixing two solutions 
ΔHmix Difference in enthalpy upon mixing two solutions 
ΔSmix Difference in entropy upon mixing two solutions 
τ Time scale 
Ax Area under the chromatographic peak 
CF Cystic fibrosis 
CLSM Confocal laser scanning microscope 
COMPACT Collaboration on the Optimization of Macromolecular Pharmaceutical Access 
to Cellular Targets 
Cx Molar concentration 
Deff Effective diffusivity 
DPn Degree of polymerization 
FG Fraction of G-monads 
FM Fraction of M-monads 
FGG Fraction of G-diads 
FGM Fraction of MG-diads 
FMM Fraction of M-diads 
FGGG Fraction of G-triads 
FGGM Fraction of GGM-traids 
FMGM Fraction of MGM-triads 
G α-ʟ-guluronate 
G’ Elastic/storage modulus 
G’’ Viscous/loss modulus 
G* Complex modulus 
G12 Alginate G-block DPn 12 
G24 Alginate G-block DPn 24 
G33 Alginate G-block DPn 33 
v | P a g e  
 
HPAEC-PAD High performance anion exchange chromatography with pulsed amperometric 
detection 
HPLC High performance liquid chromatography 
LFR Alginate LFR 5/60 
M β-ᴅ-mannuronate 
Mn Number-average molecular weight 
MPT Multiple particle tracking 
MQ Milli-Q 
MSD Mean-square displacement 
Mw Weight-average molecular weight 
mx Concentration of oligomer 
?̅?G>1 Average number of G-units in a G-block containing more than one monomer 
NMR Nuclear magnetic resonance 
PG Porcine gastric 
PIM Porcine intestinal mucus 
PSIM Porcine small intestinal mucus 
PT Particle tracking 
PTBM Porcine tracheobronchial mucus 
PTS Proline-serine-threonine 
Rfx Response factor 
SEC-MALLS Size exclusion chromatography coupled with multiangle laser light scattering 
T Temperature 
TSP Trimethylsilyl propionate 
TTHA Triethylenetetraminehexacetic acid 
Wn Weight average 
Xn Number average 
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1 Introduction 
 
1.1 Background and aim of thesis 
 
The arrival of new drugs into the pharmaceutical market has seen a decline the past few decades 
compared to the amount of money invested into drug development, characterization and production 
(Scannell et al., 2012). This is in large part due to safety concerns that warrant extensive clinical trials. 
Phase 3 of the clinical trial is commonly equally expensive as the other two phases combined, and is 
usually harder for a drug to pass (Holmgren, 2014). Because of this, research into novel drugs is often 
based on small changes to existing ones, rather than major alterations that are less likely to pass 
unopposed through the clinical trials, and is therefore less likely to be funded privately or by the 
government (Charlton, 2006). Modification of drugs concerns changing the drug formulation or 
stability, increasing circulation times or decreasing elimination times, increasing bioavailability and 
absorption rates etc. The major challenge lies in crossing the bodily barriers such as the mucus barrier, 
made difficult by a high degree of complexity.  
Most drugs are administered through the gastrointestinal tract (York, 2013), but drug delivery 
through the respiratory tract has recent years received some attention mainly due to the large surface 
area and low enzymatic activity (Patton and Byron, 2007). However, the pulmonary tract is in large 
part covered in mucus, which is a highly complex barrier. In order to improve drug delivery efficiency, 
it is important to understand the interactions and properties of the mucus barrier and assess ways of 
circumventing the restrictions related to absorption and diffusion. Alginates have shown potential to 
alter mucus flow properties (Taylor et al., 2005b, Taylor Nordgård and Draget, 2011) and has been 
shown to benefit medical and pharmaceutical sciences (Lee and Mooney, 2012). This is in large part 
due to the beneficial properties of alginate; they are biological substances, have low toxicity, are 
relatively inexpensive to manufacture, have high bioavailability and can gel in the presence of divalent 
cations. 
This project is a part of a European collaboration unit called Collaboration on the Optimization 
of Macromolecular Pharmaceutical Access to Cellular Targets (COMPACT) consisting of both academic 
and industrial partners focusing on drug development and delivery. 
The focus of this thesis is to investigate whether or not it is possible to control mucus barrier 
properties using alginate. The aim is to facilitate a drug delivery system in healthy human beings, 
meaning that the effect of alginate should be restricted to increased diffusivity across the mucus 
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barrier. The idea is therefore to examine various lengths of alginate molecules, in hopes of finding one 
that conforms to the criteria of increasing permeability without disrupting the normal mucus flow 
profile, which is important for protection from xenobiotic material. My hypothesis is as follows: 
 There exist alginate molecules with specific molecular weights with the ability to affect the 
barrier properties of mucus without changing mucus flow profile. 
 Such alginates would have the potential to be used to improve muco-penetration of 
nanomedicines in situations where modification of mucus flow properties are undesirable.  
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1.2 Mucus 
 
Mucus covers epithelial surfaces in the body exposed to the external environment and allows nutrient 
transport across the epithelial surface while protecting against potential pathogens (Cone, 2009). It 
therefore serves as a selective barrier, and is usually investigated according to its existence in three 
bodily systems – the pulmonary tract, the gastrointestinal tract and the genitourinary tract. The 
coherent mucus layer for each system has different gene products and molecular compositions 
(Khanvilkar et al., 2001). The most important subunits of mucus are the mucin glycoproteins, 
regardless of where the mucus is produced. These glycoproteins cross-link to form physically entangled 
gels (Lamont, 1992), and display a multitude of potential interaction sites which non-covalently bind 
to a variety of particles and pathogens (Woodley, 2001). Each mucus layer is therefore adapted to its 
environment making it an effective barrier.  
 
1.2.1 Composition 
Mucin. Mucin only comprises up to 5 % of mucus (Celli et al., 2005), but is considered the sole 
contributor to mucus gel formation (Sellers et al., 1988). The mucin subunits are large glycoprotein 
molecules with a molecular weight ranging from 0.5 up to 40 MDa (Lai et al., 2009, Cu and Saltzman, 
2009, Thornton and Sheehan, 2004). They are classified as being either secreted or membrane bound, 
but only the secreted mucin have gelling capacity (Strous and Dekker, 1992). There are several 
differences between these two classes of mucin, but some common features are shared between 
them. Almost all consist of a protein backbone with tandem repeat regions full of proline, threonine 
and serine residues (PTS regions) constituting 20-55 % of amino acid composition (Van Klinken et al., 
1995). The amounts and lengths of the tandem repeats vary between the different mucin gene 
products – some cell-associated mucin have PTS regions of over 5000 amino acids long (Cone, 2009). 
Bound through O-glycosylation linkages with the hydroxyl group of serine and threonine residues are 
carbohydrate molecules of 1-20 monomers. This results in a ‘bottle brush’ structure with negatively 
charged glycan side chains protruding from a protein core; the negative charges originate from sialic 
acid (pKa ≈ 2.6), sulfated galactoamines or glucosamines (both with pKa ≈ 1). Figure 1 shows a schematic 
of the structure and function of mucin molecules. The carbohydrate moieties account for up to 80 % 
of the weight of the mucin molecule (Kornfeld and Kornfeld, 1976) and are partly responsible for the 
expansion of the mucus gel. The high degree of glycosylation as well as repulsion between negative 
charges increases the persistence length of the mucin molecules 15-fold (Cone, 2009) to approximately 
15 nm (Shogren et al., 1989). The increase in persistence length gives the mucin subunits a more rigid, 
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wormlike structure instead of full flexibility, which stabilises gel formation. N-acetylgalactosamine is 
the primary carbohydrate connected to the protein backbone, but others such as N-acetylglucosamine, 
fucose, galactose, sialic acid and mannose exist to a certain degree (Bansil and Turner, 2006).  
The mucin subunits also contain ‘naked’ regions with little O-glycosylation (or N-glycosylation) 
and a high proportion (~10 %) of cysteine residues (Bansil and Turner, 2006). These regions have a 
hydrophobic characteristic and will assume a globular shape stabilised by intramolecular disulphide 
bond formation. The regions are usually found at the carboxyl and amino terminal of the protein 
backbone, but may sometimes be interspersed between the glycosylated PTS regions. Cysteine in the 
terminal areas are responsible for cross binding with other mucin subunits, thus forming a multimeric 
network (Sheehan et al., 2004). This polymerisation results in mucin aggregates with varying number 
of monomers and is essential for mucus function. Hence, mucus is polydisperse. 
 
 
Figure 1. Schematic drawing of mucin glycoproteins. Included in the figure are mucin interaction sites (Yang et al., 2012). 
 
Other components. Approximately 95 % of mucus is water (Khanvilkar et al., 2001). In addition, it 
contains various amounts of salts (mainly Na+, K+, Ca2+ and Cl-), lipids and proteins. The lipids are mainly 
in the form of free fatty acids, phospholipids and cholesterol (Bansil and Turner, 2006) and their 
presence contributes to the selectivity of the mucus membrane and protects against radicals (Cone, 
2005). They form a lipid layer at the outer edge (furthest away from the epithelial surface) of the mucus 
blanket and is stabilised by cationic surfactants that bind to the negatively charged mucin molecules. 
The reduced surface tension caused by the surface-active agents help barrier function by trapping or 
preventing hydrophobic particles or gases from penetrating the mucus layer (e.g. gastric acid in the 
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gastrointestinal tract) (Cone, 2009). The protein embedded in the mucus blanket have protective 
purposes and include immunoglobulins, lysozyme, defensins, hormones and trefoil factors (Cone, 
2005).  
Not only does the mucus layer contain various amounts of proprietary substances, it also 
harbors its own microbiota. The microbiota consists principally of bacteria and can be found lining the 
mucus layer in the oral cavity, the nasopharynx/oropharynx, the urogenital tract and the 
gastrointestinal canal (Cone, 2005). In the gastrointestinal tract alone almost 500 different species of 
bacteria has been found (Savage, 2005). Most of the microbes are commensals (most of the time) and 
do not harm the human vessel. In normal healthy individuals, the microbiota prevents the attachment 
and penetration of other pathogenic organisms, and help digest xenobiotic compounds humans are 
unable to do themselves (Savage, 2005). 
 
1.2.2 Properties 
Shear-thinning properties. Mucus displays non-Newtonian behaviour under the influence of shear 
stress (ratio of the applied force and the area of application). With increasing rate of shear stress, the 
viscosity of mucus decreases and mucus is therefore shear-thinning. The shear rate is the measure of 
slip velocity over separation distance and has the unit s-1. Viscosity is a fluids resistance to flow and is 
defined as the shear stress divided by the shear rate (Smidsrød et al., 2008). Cone (Cone, 2005) 
gathered data from various sources to determine a relationship between viscosity and shear rate in 
most human mucus (not including ovulatory/cervical mucus). This relationship is given in equation 1. 
It is clearly depicted by the equation that mucus is a shear-thinning substance, since viscosity is 
inversely proportional with shear rate. 
𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 ∝ (𝑠ℎ𝑒𝑎𝑟 𝑟𝑎𝑡𝑒)−0.85    (1) 
Due to mucus shear-thinning properties it acts as an excellent lubricant. When mucus is being 
sheared, the adhesive contact and entanglements between the mucin molecules are pulled apart, 
which creates a slippage plane (Cone, 2009). The slippage plane is depicted in Figure 2. It has also been 
shown (Raviv et al., 2003) that negative charges on polymers in general enhance lubrication effects 
through electrostatic repulsion. In the case of mucus, such repulsion causes the mucin polymers to 
associate with each other less tightly, greatly reducing close contact between them. This helps reduce 
the viscosity of mucus under applied shear stress. 
Shear thinning properties can either be permanent or temporary. Mucus generally exhibit 
temporary displacement, and is classified as thixotropic. This is an important property of pulmonary 
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mucus in relation to coughing (Houtmeyers et al., 1999). Instead of irreversibly breaking bonds, the 
mucin polymers pull apart when under applied deformation and will partially recoil to its original 
position (Crystal, 1997). It still maintains gel integrity, meaning that the deformation process is 
reversible. This separates mucus from most other polymeric gels (e.g. alginate gels) which cannot 
reform as a gel once the mechanism(s) holding it together ruptures. Mucus depends on both 
entanglements and interactions in order to gel. The degree of entanglements depends on mucin 
concentration, length of mucin subunits and the chemical nature of the mucin molecules (Thornton 
and Sheehan, 2004).  
 
 
Figure 2. The ability of mucus to form a slippage plane, thus acting as an excellent lubricant. As shear rates increases, the 
adhesive and entangled mucin molecules pulls apart (Cone, 2009). 
 
Viscoelasticity. Mucus exhibit both liquid and elastic properties and is therefore viscoelastic. Exposing 
mucus to small displacement forces (i.e. small strain) will cause the mucin polymers to stretch rather 
than pull apart or disentangle (Cone, 2009). After the applied force is released, the gel will return partly 
to its original state. This is the elastic characteristic of mucus, but it also displays a viscous character 
because it flows. The viscoelasticity of mucus is crucial for normal transport of mucus from the 
respiratory tract. Mucus is transported out of the lung by two main mechanisms – either by mucociliary 
actions or through coughing. Additionally, a third mechanism called alveolar clearance may also occur 
for insoluble particles deposited on the respiratory surface of the lung (Houtmeyers et al., 1999). Cough 
clearance of mucus is considered the secondary clearing mechanism, and usually happens only when 
mucociliary clearance is insufficient (King, 1998). The effectiveness of cough clearance is highly 
dependent on mucus viscosity, but is also affected by mucus spinnability and adhesivity (King et al., 
1989). The primary clearance mechanism relies on the action of cilia found on ciliated epithelial cells 
throughout the respiratory tract. The cilia beat independently, although co-ordinated, on the mucus 
blanket with a shearing force that is small and sufficiently frequent to make the mucus layer respond 
through elastic forces rather than viscous ones (Cone, 2009). Cilia move in a whipping motion, and will 
temporarily connect with the mucus blanket only when they are fully extended. In their relaxed state, 
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when the cilia bend back to their original position, the movement takes place in the periciliary layer. 
This layer is a densely populated macromolecular solution that surrounds the cilia (Button et al., 2012). 
The thickness of the periciliary layer is normally slightly less than the length of the cilia, therefore 
allowing only the tips to touch the mucus blanket when fully extended (Houtmeyers et al., 1999). 
Because there is a unidirectional contact between the cilia and the mucus layer, the mucus layer is 
translocated in a cephalic direction – towards the glottis where mucus and trapped particles enter the 
gastrointestinal tract. Mucociliary clearance in the pulmonary tract depends on the ciliary beat 
frequency, viscosity and depth of the periciliary layer and the viscoelasticity of the mucus layer (Bates, 
1989). Most important is the viscoelastic properties of mucus, and alteration of its normal condition 
may have adverse effects on human physiology. If mucus becomes too liquid, gravitational forces 
overcome the ciliary function and the mucus seeps back into the lungs instead of being shuttled 
through the glottis. This could potentially facilitate bacterial motility, increasing the chance of 
infections. Similarly, if mucus becomes too viscous, cilia beating becomes insufficient as transportation 
mechanism. This happens in various pulmonary diseases – e.g. cystic fibrosis. When the mucus 
becomes too elastic, most particle mobility ceases. This includes the movement of proprietary 
immunological substances, which decreases the defensive capacity towards bacterial and viral 
infections (Cone, 2009).  
 
Barrier properties. The barrier functionality of mucus depends on three different characteristics 
(Sanders et al., 2009): 
1. Mucus has dynamic properties. It is constantly secreted, which washes away most particles 
and bacteria that might cause harm to the parent organism. The rate of secretion depends on 
location and pathological conditions, but a healthy human adult secretes ~10 L every day, 
mostly in the gastrointestinal tract (Ensign et al., 2012). This means that pathogens or particles 
must constantly migrate or diffuse against an outward current in order to reach the epithelial 
surface for absorption. 
2. Mucus is a steric barrier. The mucin polymeric network is entangled and will therefore 
physically obstruct particles trying to migrate through the mucus layer. The degree of steric 
hindrance (i.e. pore size) depends on the length of mucin subunits, the extent of cross binding 
and the chemistry of the mucin molecules which decides the adhesiveness between mucin 
subunits (Thornton and Sheehan, 2004). The mesh spacing is very heterogeneous in mucus, 
e.g. mucus lining porcine trachea had mesh sizes ranging from 80 to 1500 nm (Yang et al., 
2012). 
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3. Mucus is interactive. Mucus does not normally covalently attach to particles, but rather exhibit 
a wide range of different weak interactions that non-specifically bind to foreign matter. It has 
been shown that the oligosaccharide side chains of mucin are responsible for electrostatic 
interactions and non-specific hydrogen bonding, while the protein backbone itself allows for 
hydrophobic interactions (Khanvilkar et al., 2001). In addition, mucus can also adhere to 
particles by van der Waals interactions (Woodley, 2001). Such low-affinity bonds have short 
half-lives, and are often broken due to thermal energy within milliseconds. However, mucus 
exhibit a plethora of these low-affinity bonds at any given time, which keep particles trapped 
(Cone, 2009). Because of the varied display of interaction modes, mucus is well adapted to 
trap particles that have hydrophobic or negatively/positively charged surfaces. Hydrophobic 
surfaces would attract the hydrophobic domain on the mucin protein backbone, and positively 
charged surfaces would attract the negatively charged glycan side-chains. Negatively charged 
surfaces are not likely to be attracted, but rather repelled by the glycan side-chains. Studies 
into virus and protein exterior structure have revealed that particles with a high degree of 
negative and positive charges, but without any net charge are more likely to partition into the 
mucus layer unopposed (Cone, 2009).  
 
1.2.3 Porcine gastric mucin 
Porcine gastric (PG) mucin has been shown to be structurally related to human gastric mucin (Turner 
et al., 1999), and is therefore a decent substitute for human gastric mucin because of higher availability 
and less ethical issues. In addition, MUC5AC is highly expressed in both the stomach and the 
tracheobronchial tract (Van Klinken et al., 1995), meaning that using porcine gastric mucin as a 
representation of pulmonary mucin is viable. PG mucin can be acquired in different ways; 
commercialised crude isolated PG mucin or natural purified PG mucin scraped off a pig stomach. One 
research group (Kočevar-Nared et al., 1997) showed that Sigma crude PG mucin did not have the same 
rheological properties as natural PG mucin, thus having limited usage as gastric mucin substitute. The 
crude PG mucin had very stable rheological values, but did not show the existence of an elastic, stable 
and strong gel network like the natural PG mucin. This effect has been ascribed to the extensive 
degradation of the mucin molecules. Degraded mucin appear as separate randomly coiled monomers 
in solution, instead of a polymeric network, and cannot form an elastic gel (Cone, 2009). 
PG mucin undergoes a pH dependent sol-gel transition that is crucial for the mucus layer to 
remain protective in the gastrointestinal tract due to high variations in pH (Celli et al., 2005). Other 
factors also contribute to the gastric acid neutralisation such as the lipid layer and outward secretion 
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of mucus (Cone, 2005). Studies have shown (Cao et al., 1999, Celli et al., 2005) that the phase change 
threshold is around pH 4 with mucin concentrations greater than 10 mg/mL. The pH affects the 
conformation of mucin in solution, expanding the structure at lower pH, which increases the 
persistence length of PG mucin from 8 nm at pH 7 to 43 nm at pH 2 (Cao et al., 1999). Studies have 
shown that PG mucin aggregates at low pH (Bhaskar et al., 1991, Hong et al., 2005), and that the 
aggregation is most likely caused by hydrophobic and electrostatic interaction (Cao et al., 1999, 
Bhaskar et al., 1991, Bansil and Turner, 2006). Exactly how this happens is unclear, but it involves the 
hydrophobic parts of the protein backbone of mucin molecules (Lee et al., 2005). The pH threshold is 
around the pKa value of the negatively charged amino acids (aspartic acid and glutamic acid) 
interspersed on the protein backbone (Cao et al., 1999). The result from lowering pH will be a thicker, 
more solid dominant gel. 
 
 
1.3 Alginates 
 
Alginates are a family of linear copolymers, containing blocks of (1→4)-linked β-ᴅ-mannuronate (M) 
and α-ʟ-guluronate (G) residues. The block composition and sequence as well as molecular weight vary 
according to the organism that produces the alginate (Smidsrød et al., 2008). By 2012 over 200 
different alginate molecules were commercially available (Lee and Mooney, 2012). Commercial 
alginate is typically extracted from brown algae (Phaeophyceae), where it is used as structural support. 
Bacterial species of Azotobacter and Pseudomonas also produce them, and may provide more defined 
structural and physical properties than seaweed derived alginate (Lee and Mooney, 2012). Alginates 
are comprised of three different block structures – consecutive G residues known as G-blocks (e.g. 
GGGGG), consecutive M residues known as M-blocks (e.g. MMMMM) and alternating M and G 
residues known as MG-blocks (e.g. MGMGM). The structural characteristics of alginates are shown in 
Figure 3. G residues are known to be important for gel formation of alginates by binding most divalent 
cations (especially Ca2+). This is because alginates are polyanions in solution with pH above the pKa (~ 
4 pH) value of the carboxylic acid attached to the uronic acids (M and G). In addition, the G residues 
assume a 1C4 confirmation and many G residues in succession form cavities, which selectively bind 
divalent cations. MG-blocks might also participate in gel establishment, but generally leads to weaker 
gels (Pawar and Edgar, 2012). 
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Figure 3. Structural characteristics of alginate: (a) structure of β-ᴅ-mannuronate and α-ʟ-guluronate, (b) type of linkind and 
general confirmation and (c) block distribution (Draget and Taylor, 2011). 
 
Alginates are susceptible to degradation at neutral (by reducing compounds), basic (β-
elimination) and acidic (acid hydrolysis) pH. Acid hydrolysis is, however, the most common way of 
selectively degrading alginates. The mechanism behind the process was described by Timell in 1964 
(Timell, 1964) and involves three steps; (1) the glycosidic oxygen between two consecutive monomers 
protonates; (2) the monomers split by hydrolysis of the glycosidic bond, forming a non-reducing end 
and a carbonium-oxonium ion; and (3) addition of water changes the carbonium-oxonium ion into a 
reducing end. 
Alginates are interesting candidates in biomedical applications, and have been implemented 
in pharmaceutical and medical industries (Draget and Taylor, 2011). They are extensively used in 
wound healing, and have been investigated for use in delivery of drugs, tissue regeneration and in vitro 
cell culturing (Lee and Mooney, 2012). The main reason is their biocompatibility and low toxicity. 
Alginates are also readily modified to create derivatives with altered physical and chemical properties, 
which might for instance positively influence drug bioavailability. In addition, alginates gel under 
relatively mild conditions, which would minimize risk of denaturing the cargo. Alginates have been 
shown to influence mucus and mucin rheology (Taylor et al., 2005b, Taylor Nordgård and Draget, 
2011); high molecular weight alginates increases the mechanical properties of PG mucin, while low 
molecular weight G-blocks decrease mechanical properties (Draget and Taylor, 2011). Generally, G-
blocks are preferred in a drug delivery context since they have been shown to be non-immunogenic 
(Otterlei et al., 1991). 
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1.4 Rheology 
 
Rheology is the study of deformation and flow of matter, and is a useful technique for biopolymer 
solution/gel characterization. The method is efficient at measuring the bulk flow profiles of viscoelastic 
materials (Deshpande et al., 2010). Most materials have viscoelastic behaviour, meaning they display 
a combination of both liquid and elastic properties. This is a time dependent behaviour, and even 
mountains behave as a liquid if studied at an appropriately long time-scale. This means that a material 
appears elastic either because the time perspective of the deformation process is very fast, or because 
the material itself has a long characteristic time (Barnes et al., 1989). In order to measure these 
properties the material in question is subjected to an applied rotational force (torque) quantified as 
the shear stress which causes the material to deform, called the shear strain. These measurements are 
stress controlled, but there also exist strain controlled experiments. In strain controlled experiments 
the strain is held constant, and the induced stress needed to maintain the constant strain is measured.  
Usually, the material of interest is deposited between a cone and plate geometry; the plate is 
stationary and the cone has controllable movement. The cone and plate geometry is often preferred 
over the double plate geometry because the shear stress will be approximately uniform throughout 
the sample, provided the angle of the cone is small (Barnes et al., 1989). The cone is moved with a 
force (shear stress) that mechanically deforms the material. The resultant deformation of the sample 
– i.e. the degree of displacement from the initial position, is the shear strain and can be measured. The 
shear stress can be applied linearly or oscillatory. Oscillatory measurements are increasingly used 
because it allows for observation of material response as a function of frequency, and can therefore 
be used to describe viscoelastic behaviour over several time-scales (Deshpande et al., 2010). Because 
of this, it is an efficient mode for investigating the linear viscoelastic region of a material. The linear 
viscoelastic region of a material is where strain ∝ stress and storage modulus (G’), loss modulus (G’’) 
and complex modulus (G*) are independent of strain. Most materials have one or two regions where 
this is true, but the width of the region(s) varies. In oscillatory experiments the measurements happen 
during a frequency determined oscillation. The applied stress and resultant strain vary cyclically with 
the frequency of oscillation, usually in a sinusoidal manner (Deshpande et al., 2010). The relationship 
between stress and strain during one cycle can be illustrated through sinus plot or Lissajous plot as 
seen in Figure 4.  
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Figure 4. Sinus and Lissajous plot illustrating the relationship between stress and strain. The left image shows how the 
difference between stress and strain during sinusoidal oscillation relays the phase angle values, which is a measure of the 
amount of liquid and solid properties in a sample (Vader and Wyss). The right image shows how the Lissajous plot would look 
for elastic, viscous and viscoelastic materials (Deshpande et al., 2010) 
 
For pure elastic materials both stress and strain are in phase with each other. In other words, 
the phase angle (δ) between the stress and strain curve equals zero. For pure liquid materials the strain 
is π/2 out of phase compared to the stress (δ = 90 °). Viscoelastic materials will have phase angle values 
somewhere between these extremities (0 ° < δ > 90 °). The viscoelastic character at any given frequency 
of oscillation is characterized by the storage/elastic modulus (G’) and the loss/viscous modulus (G”), 
which quantify the solid-like and liquid-like contribution to the measured stress response respectively 
(Weitz et al., 2007). The storage modulus correlates with the in-phase behaviour, while the loss 
modulus correlates with the out-of-phase behaviour of the material, meaning that there is a close 
relationship between the phase angle (δ) and both moduli. This relationship is presented in Figure 5. 
 
 
Figure 5. Relationship between the rheological parameters. G* is the complex modulus, G’ is the storage/elastic modulus, G” 
is the loss/viscous modulus and δ is the phase angle. 
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1.5 Multiple particle tracking 
 
Studying the mobility of particles is important in order to achieve a better understanding of the 
mechanisms that impede drug diffusion and movement from place of administration to target site. 
Drug delivery limitations often revolve around inefficient transport through complex bodily fluids such 
as mucus (Suh et al., 2005), which acts as a highly specialized selective barrier to most particles (Cone, 
2009). It is therefore important to investigate how diffusion rates and particle mobility changes under 
external influence, e.g. by the addition of muco-adhesive agents. For this purpose, particle tracking is 
a useful technique. It is non-invasive and allows for real-time tracking of single particles on the 
micrometre scale using video microscopy (Suh et al., 2005). The technique can be extended to track 
multiple particles simultaneously, and is well equipped to identify particle speed, trajectories and 
mode of transport in various environments. Particle mobility depends on physical obstacles within the 
medium and on interactions between particle and medium (Figure 6) (Lieleg et al., 2010). It is therefore 
possible to determine structural characteristics (e.g. pore size and structural inhomogeneities) and 
interactive capabilities of the environment (Suh et al., 2005). Because multiple particle tracking (MPT) 
allows for tracking of many particles simultaneously, particle mobility can be studied at single particle 
level, subpopulation level or at bulk population level. 
 
 
Figure 6. Two modes of particle impediment through mucus/mucin matrices. The hydrogel can impede mobility by physical 
obstruction, or through interactions (Lieleg and Ribbeck, 2011). 
 
Fluorescent particles can be tracked by the MPT technique using an epifluorescence microscope (e.g. 
confocal microscope) by registering the spatiotemporal position (x-, y-, z- coordinates and time) of 
each particle. The particles are usually excited by a light beam originating from a mercury lamp, and 
the resulting emission spectra is detected and used to determine particle position. The spatiotemporal 
positions can be used to calculate trajectories for each tracked particle and can further be used to 
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calculate mean-square displacement (MSD) values. MSD values, which correlate to the distance 
travelled from the initial position over time (Selvaggi et al., 2010), can then be used to calculate 
effective diffusivities (Deff) used to determine the mode of particle transport (Suh et al., 2005). The 
equation used to calculate two-dimensional MSD values and Deff values are given in equation 2 and 3 
respectively. Both values are calculated in regards to time scale (τ) which is determined by the speed 
of the camera capturing images in frames per second (fps). If the camera takes 30 frames every second, 
each frame will be approximately 33 milliseconds apart, corresponding to an initial time scale of 33 
ms. The following time scale values would in this case be 66 ms, 99 ms, 132 ms and so on. The MSD 
values for a given particle, will be calculated per value of time scale.  
𝑀𝑆𝐷(𝜏) = 〈∆𝑥2 + ∆𝑦2〉                                                              (2) 
𝐷𝑒𝑓𝑓 =
𝑀𝑆𝐷(𝜏)
4𝜏
      (3) 
Δx2 and Δy2 is the difference in x- and y-coordinates respectively between two consecutive frames and 
τ is the time scale. This means that for a video of 200 frames, the first MSD value that would be 
calculated at the shortest time scale (33 ms) will be a mean of 199 separate displacement values. The 
second MSD value, calculated at the second shortest time scale (66 ms), will be a mean of 198 separate 
displacement values. This continues until the final MSD value is calculated at the longest time scale 
(6.567 s) with only one displacement value. The calculation principle of MSD values is graphically 
depicted in Figure 7. Due to the gradually decreasing amount of displacement values as the time scale 
increases, the contribution of the MSD values based on large time scales to particle movement is 
statistically inaccurate. This means that MSD values at the longest time scales often can be disregarded 
during data analysis (Saxton and Jacobson, 1997). 
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Figure 7. Graphical presentation on how to calculate mean-square displacement (MSD) values. The graph shows a particles 
trajectory (i.e. position at a given time), and the left shows how MSD values are calculated according to time scale (τ) that 
does not equal the time, but rather the time in between two frames. n here is the number of frames the particle in question 
was tracked. 
 
The effective diffusivities (Deff) plotted against time scale can be used to determine the type of 
movement of the particles embedded within the viscoelastic material. The relationship between the 
effective diffusivity trajectories and particle movement is shown in Figure 8. Particles are classified as 
either diffusive (i.e. they move according to Brownian motion), sub-diffusive or active. Diffusive 
particles can sometimes be immobile because of movement of the viscoelastic material itself that the 
particles are immersed in, or by physical/chemical entrapment (Suh et al., 2005). Another possibility is 
that the viscoelastic material contain compartments that restrict the particles to move meso- or 
macroscopically, but not microscopically.  
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Figure 8. Particle mobility determined through Deff values; active (▴), sub-diffusive (●) and diffusive/immobile (□) (Suh et al., 
2005). 
 
1.6 Alginate characterization 
 
The alginate samples that were used in this master thesis were characterized using standard analytical 
methods. The G-block samples were characterized both by nuclear magnetic resonance (NMR) 
spectroscopy and high performance anion exchange chromatography with pulsed amperometric 
detection (HPAEC-PAD), while the alginate LFR 5/60 was characterized by size exclusion 
chromatography coupled with multiangle laser light scattering (SEC-MALLS). 
 
1.6.1 NMR 
NMR is an extensively used analytical method for structure elucidation of compounds. One of the main 
advantages of NMR is that the method can be used to provide both qualitative and quantitative 
information. An atom with a magnetically active nucleus will, under an applied magnetic field, give rise 
to a signal corresponding to the location of that atom. The signal varies according to the positioning of 
that atom on the molecule, and what kind of physical and chemical environment it is in (Friebolin, 
1991). The strength of the signal indicates the amount of atoms present giving rise to those signals, 
and the position of signals correlates with the molecular arrangement of the compound in question. 
In this thesis NMR was used to determine the fractions of monads, diads and triads of G and M (FG, FM, 
FGG, FMM, FGGG, FGGM etc.), the degree of polymerization (DPn) and the average number of G-units in a 
G-block containing more than one monomer (?̅?G>1) (Smidsrød et al., 2008).  
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1.6.2 Chromatography 
Chromatography is a collection of various analytical methods, used primarily for the separation and 
quantification of compounds. The methods usually vary in regards to the separation technique and the 
mode of detection, but the principle is that a compound with a given characteristic (e.g. size, charge, 
hydrophilicity etc.) is retained differently within the chromatographic column than compounds that do 
not have identically matching characteristic (Poole, 2003). HPAEC-PAD separates compounds based on 
the amount of negative charges, and will therefore efficiently separate different chain lengths of 
alginate G-blocks (Ballance et al., 2005). The method can be used to determine the degree of 
polymerization. It also distinctly shows the distribution of various chain lengths, and is therefore a good 
supplement to the NMR technique. SEC-MALLS is a chromatographic method coupled with light 
scattering detection, and uses size as separation mechanism. The method is used to determine the 
molecular weight (Mw) of the compound in question, and can provide information on molecular weight 
distribution of the sample. 
  
18 | P a g e  
 
2 Materials and methods 
 
2.1 Materials 
 
2.1.1 Bio-similar mucus 
The bio-similar mucus was made according to a protocol designed by COMPACT collaboration partners 
at the University of Copenhagen, Denmark. The bio-similar mucus was optimized to represent a 
rheologically comparable substitute for porcine intestinal mucus (PIM). Through having a similar 
rheological profile to PIM, the bio-similar mucus represents a synthetic model that can be used to 
assess in vitro mucosal influence on drug absorption (Bøgh et al., 2013). The bio-similar mucus was 
made using CaCl2, MgSO4, NaCl from Merck (Dermstadt, Germany), L-α-phosphatidylcholine, linoleic 
acid, cholesterol, HEPES, polysorbate tween 80, Sigma mucin type II: crude and bovine albumin from 
Sigma-Aldrich Co. (St. Louis, USA) and carbopol 934P (polyacrylic acid, batch#DS9068) from Recklitt & 
Colman Products (Kingston upon Hull, UK). Salts were mixed with HEPES to make one isotonic, and one 
non-isotonic HEPES buffer to be used in the lipid and polymeric solution respectively. The lipid (L-α-
phosphatidylcholine, linoleic acid, cholesterol and polysorbate tween 80) and polymeric (Sigma mucin 
type II: crude and carbopol 934P) compounds were mixed separately to give homogeneous solutions 
before the lipid solution was aliquoted to the polymeric solution. Bovine albumin was then added 
before pH was adjusted to give physiological pH. The protocol that was used to make the bio-similar 
mucus is given in Appendix A. Several batches of bio-similar mucus were made during the course of 
the master thesis, with minor variations in lipid composition since the lipid samples were hard to 
handle, and only small amounts were needed. Adjusted pH was in all batches were in the range of 7.40 
± 0.01. 
 
2.1.2 Native porcine small intestinal mucus and porcine tracheobronchial mucus  
Intestines of freshly slaughtered pigs were given to Professor Kurt I. Draget from Gilde slaughterhouse 
in Steinkjer. The intestines were cut open using a scissor/scalpel and the mucus scraped using spoons. 
The collected mucus were separated by location (tracheobronchial tract, stomach, small intestine) into 
beakers and stored at -20 °C. 
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2.1.3 Porcine gastric mucin 
Samples of PG mucin was purchased from Professor J. P. Pearson at Institute of Cell and Molecular 
Biosciences at the University of Newcastle upon Tyne, UK. The protocol for PG mucin collection and 
purification is given in Appendix B. 
 
2.1.4 Alginate 
Four different alginate samples has been used in this thesis – alginate G-block DPn 12, alginate G-block 
DPn 24, alginate G-block DPn 33 and alginate LFR 5/60. Alginate LFR 5/60 are guluronate rich molecules 
(FG = 0.69) and was purchased from Pronova Biopolymer (Drammen, Norway). The alginate was 
produced by Laminaria hyperborea (kelp) and should have a molecular weight (Mw) of around 30-50 
kDa. However, because the sample was from 1993, it was characterized using SEC-MALLS, and found 
to have a weight- average molecular weight (Mw) of 32.6 kDa and molecular weight distribution of ~10-
80 kDa. The SEC-MALLS chromatogram and data analysis is given in Appendix C. The SEC-MALLS 
characterization found that the alginate LFR 5/60 solution contained some aggregates, so the Mw was 
calculated by exponential fit of the data.  
Alginate G-block DPn 24 was purified by acid precipitation from alginate sample “G-blokk H3” 
and alginate G-block DPn 33 was purified from alginate sample “G-blokk Batch#801-255-02”, both a 
gift to Professor Kurt I. Draget from FMC Biopolymer AS (Drammen, Norway). Alginate DPn 12 was 
produced by acid hydrolysis of “G-blokk H3”. The protocol for purification of alginate G-block DPn 24/33 
and the production of alginate G-block DPn 12 is given in Table 1 and Table 2 respectively. 
 
Table 1. Protocol and actual procedure for purification by acid precipitation of “G-blokk H3” and “G-blokk Batch#301-255-02” 
to give alginate G-block DPn 24 and G-block DPn 33. 
Step Protocol Actual/Comments 
1 Mix 2 % alginate solution using MQ-water. 
Make sure the solution is homogenous by 
magnetic stirring before continuing. 
30.05 g “G-blokk H3” in 1.5 L MQ-water and 9.99 g 
“G-blokk Batch#801-255-02” in 0.5 L MQ-water. 
2 Adjust pH to 2.8. “G-blokk H3” → 2.803 pH. 
“G-blokk Batch#301-255-02” → 2.803 pH. 
3 Leave solution on stirrer for 2.5 hours. 
Cover solution with aluminium. 
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4 Centrifuge at 1750 rpm for 15 minutes. The DPn 24 solution was divided in three beakers, to 
even out the weight. 
5 Discard supernatant, and resuspend 
sample in 0.25 mL 0.01 M HCl. 
Four 250 mL centrifuge bottles were used, and 0.01 
M HCl was added to the rim of the bottles. 
Approximately 175 mL per bottle.  
6 Centrifuge as in step 4. Samples were centrifuged at 1500 rpm for 10 
minutes, and further 7 minutes at 1700 rpm. The 
extra spin was due to improper sedimentation. 
7 Discard supernatant, and resuspend 
sample in 0.25 mL MQ-water. 
The centrifuge bottles were filled to the rim with MQ-
water. Approximately 175 mL per bottle. 
8 Centrifuge as in step 4. Samples were centrifuged at 1700 rpm for 13 
minutes, and further 6 minutes at 2000 rpm. The 
extra spin was due to improper sedimentation. 
9 Discard supernatant, and resuspend 
sample in 0.25 mL MQ-water. Neutralize 
solution with 0.5 M NaOH to pH 7. 
“G-blokk H3” was resuspended in 500 mL MQ-water, 
while “G-blokk Batch#301-255-02” was resuspended 
in 250 mL MQ-water. 
“G-blokk H3” → 7.021 pH. 
“G-blokk Batch#301-255-02” → 7.263 pH. 
Solutions were neutralized using 50 % NaOH and 4 M 
NaOH. 
10 Filter solution. Both solutions were filtered through a GF/A filter 
from Whatman PLC (Maidstone, UK) with help of a 
diaphragm vacuum pump.  
11 Freeze dry sample. The samples were frozen in liquid nitrogen (N2) from 
Yara International ASA (Oslo, Norway) while spinning 
on an evaporator, and then placed on an Alpha 1-4 LD 
freeze-drying unit from Martin Christ 
Gefriertrocknungsanlagen GmbH (Osterode am Harz, 
Germany) freeze-drying unit operating at 0.1 mbar 
and -60 °C. The samples were left on the freeze-
drying unit for two days. 
12 Collect and store the sample dark at room 
temperature. 
The powders were stored in separate zip-lock bags. 
Calculated yield of “G-blokk H3” was 47.69 %, and 
56.86 % for “G-blokk Batch#301-255-02”. 
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Table 2. Protocol and actual procedure for acid hydrolysis of newly purified “G-blokk H3” to give alginate G-block DPn 12. 
Step Protocol Actual/Comments 
1 Mix 1 % alginate solution using MQ-water. 
Make sure the solution is homogenous by 
magnetic stirring before continuing. 
10.01 g “G-blokk H3” in 1 L MQ-water. 
2 Adjust pH to 3.6 using 1 M HCl. Important that 
nothing precipitates. 
“G-blokk H3” → 3.601 pH.  
Mixture was turbid, but no precipitation could 
be seen. 
3 Bubble through the solution with nitrogen 
gass for 2-3 minutes. 
N2 (g) from Yara International ASA (Oslo, 
Norway) was bubbled through the solution for 3 
minutes at 0.5 bar. 
4 Place solution in 95 °C water bath for exactly 
12 hours. 
 
5 Cool solution quickly in an ice bath.  
6 When solution reaches room temperature, 
neutralize it with 0.5 M NaOH to pH 7. 
“G-blokk H3” → 7.000 pH. 
Solution was neutralized to using 1 M NaOH. 
7 Dialyse solution through a membrane with 
molecular weight cut-off (MCOW) 12-14,000 
until conductivity is <2 µS. 
Before dialysis, the sample was concentrated by 
evaporation (1 L → 0.41 L). Solution was 
transferred to two Spectra/Por Dialysis 
Membrane with MWCO 12-14,000 with 29 mm 
diameter from Spectrum® Laboratories Inc. 
(Rancho Dominguez, USA). The dialysis bags 
were left in distilled water the first two days, and 
MQ-water the third. The conductivity was 
checked before every water change (after 
changing to MQ-water). The conductivity 
jumped up and down, which probably meant 
that one of the hoses had a leak, and when the 
samples were removed the conductivity was 5.1 
µS. 
8 Filter solution. Solution was filtered through a GF/A filter with 
help of a diaphragm vacuum pump. Before 
filtering the solution was concentrated by 
evaporation (2.1 L → 0.5 L). 
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9 Freeze dry sample. The sample was frozen in N2 (l) while spinning on 
an evaporator, and then freeze dried at 0.1 mbar 
and -60 °C. The samples were left on the freeze-
drying unit for two days. 
10 Collect and store the sample dark at room 
temperature. 
The powder was stored in a zip-lock bag. 
Calculated yield of the alginate G-block DPn 12 
sample was 44.36 %. 
 
 
All three alginate G-block samples were characterized using 1H NMR and HPAEC-PAD. The NMR 
technique was used to determine the number-average degree of polymerization (DPn), the monad, 
diad and triad fraction of guluronate and mannuronate (FG, FM, FGG, FGM, FMM, FGGG etc.) and the average 
number of G-units in a G-block containing more than one monomer (?̅?G>1). The HPAEC-PAD technique 
was used to determine DPn for all samples, and provides information on the molecular distribution of 
the samples. The data collected from both samples are given in   
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Table 3. The NMR and HPAEC-PAD methods disagreed on the average chain length of the 
alginate molecules (DPn), but it was decided to follow the NMR results because the HPAEC-PAD method 
suffers from poor resolution at long polymer chain lengths of 30-35 (Ballance et al., 2005). This is 
probably the reason why the discrepancy between DPn values from the two methods are larger 
alginate G-block DPn 33 than for alginate G-block DPn 12. Spectra and calculations for NMR and HPAEC-
PAD values are given in Appendix D and E respectively. The reader may have noticed that the average 
number of G-units in a G-block containing more than one monomer (?̅?G>1) is very high for the smallest 
sample, and show ?̅?G>1 values that are higher than the number average degree of polymerization (DPn). 
This is because ?̅?G>1 is calculated under the assumption of infinitely long chain lengths, which in this 
case is not true. The values should be disregarded.  
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Table 3. Number-average degree of polymerization (DPn), monad, diad and triad fraction of mannuronate and guluronate (FG, 
FM, FGG, FGM, FMM, FGGG etc.) and the average number of G-units in a G-block containing more than one monomer (?̅?G>1) for 
alginate G-block DPn 12, alginate G-block DPn 24 and alginate G-block DPn 33. Values are determined mostly from 1H NMR, 
but HPAEC-PAD was also used to confirm the DPn value. 
 Alginate G-block DPn 33 Alginate G-block DPn 24 Alginate G-block DPn 12 
FG total 0.868 0.899 0.932 
FG internal 0.837 0.857 0.850 
FG reducing ends 0.031 0.042 0.082 
FM 0.132 0.101 0.068 
FGG internal 0.784 0.818 0.826 
FGM = FMG 0.052 0.040 0.024 
FMM 0.080 0.061 0.044 
FGGM = FMGG 0.032 0.027 0.017 
FMGM 0.020 0.013 0.007 
FGGG internal 0.752 0.791 0.809 
?̅?G>1 26 33 55 
DPn NMR 33 24 12 
DPn HPAEC-PAD 36 24.5 12 
 
 
2.2 Methods 
 
2.2.1 Preparation of mucus-alginate solutions 
The water used was of Milli-Q water (MQ-water) quality unless otherwise specified. Isotonic alginate 
solutions of G-block DPn 12, G-block DPn 33 and LFR 5/60 (70 mg/mL) was separately added to different 
samples of bio-similar mucus to a concentration of 4.7 mg/mL. Isotonic saline was used as control to 
eliminate dilution effects and ionic strength differences (143 µL saline in 2 g bio-similar mucus). The 
isotonic solutions were added, and the mixture properly stirred using a pipette tip three times with 10 
minutes intervals. The same protocol was followed for addition of alginate/saline solutions to the 
native porcine mucus samples as to the bio-similar mucus sample. However, for the porcine 
tracheobronchial mucus (PTBM) sample, the concentration of alginate was 3.4 mg/mL, and no control 
was used due to low sample availability. 
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2.2.2 Preparation of porcine gastric mucin-alginate solutions 
The water used here was of Milli-Q water quality unless otherwise specified. Two different lots of 
porcine gastric (PG) mucin have been used in this thesis. They are denoted as lot#1 and lot#2 
respectively. Freeze-dried PG mucin was dissolved in MQ-water at a concentration of 42.84 mg/mL in 
order to achieve a final PG mucin concentration after addition of alginate/saline of 40 mg/mL. The 
solution was left in storage at 3 °C for 48 hours with gentle mechanical stirring. Vigorous stirring was 
avoided because this could lead to bubble formation in the mucin samples. After completed 
rehydration, the samples were aliquoted in 0.5 g amounts in Eppendorf tubes and stored at -20 °C. 
Several different concentrations, hydration media and hydration times were tried for the rehydration 
of PG mucin. MQ-water was chosen as medium because the resulting hydrated PG mucin solution was 
visually more viscous and gel-like than using 50 mM NaCl medium or 10 mM HEPES buffer medium. 
The optimal concentration was determined to be 40 mg/mL. Frequency sweeps of PG mucin at 50 
mg/mL and 60 mg/mL concentrations resulted in a high degree of noise, most likely due to suspended 
PG mucin rather than dissolved PG mucin in the MQ-water medium. After several frequency sweeps 
of PG mucin with only hydration time as variable, it was found that hydration time influenced PG mucin 
rheology. All samples were therefore left to hydrate for precisely 48 hours. 
Isotonic alginate solutions of G-block DPn 12, G-block DPn 24, G-block DPn 33 and LFR 5/60 (70 
mg/mL) was separately added to different Eppendorf tubes containing PG mucin to a final alginate 
concentration of 4.7 mg/mL. Isotonic saline was used as control to eliminate dilution effects and ionic 
strength differences (35.5 µL saline in 0.5 g PG mucin). The isotonic solutions were added, and the 
mixture properly stirred using a pipette tip three times with 10 minutes intervals. 
 
2.2.3 Rheology 
All rheological measurements were carried out using a Reologica StressTech rheometer (Lund, 
Sweden, Serial no. 212-0683) in oscillatory mode. The machine was fitted with a cone-and-plate 
geometry for small deformation measurements. The cone dimension varied according to material 
availability, ranging from C 25 1 ETC to C 50 1 ETC. The left number (25/50) relates to the cone 
diameter, while the right number corresponds to the angle of the cone from the centre outwards (1 = 
1 °). All samples were rheologically tested through frequency sweeps. Frequency sweeps were mostly 
carried out after a strain sweep at 1 Hz frequency in order to determine parameters for the frequency 
sweep where stress ∝ strain and where the moduli are independent on strain (i.e. the linear 
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viscoelastic area). Every frequency sweep given in this thesis display values that are an average of three 
measurements. All mucus samples were rheologically tested at 20 °C, while PG mucin samples were 
tested at 10 °C. All samples applied on the rheometer was covered with low viscosity oil (Dow Corning 
® 200/10cS fluid) from VWR International Ltd. (Butterworth, UK) to prevent evaporation. Rheologica 
software RheoExplorer version 5.0.40.38 was used for instrument control and data analysis. 
 
2.2.4 Particle tracking 
Samples for particle tracking were prepared by first measuring out 0.2 g of PG mucin (42.84 mg/mL) 
into chambers of Lab-Tek ® Chambered #1.0 Borosilicate Coverglass system from Thermo Fisher 
Scientific Inc. (NY, USA. Lot#1065778 2711). Fluospheres ® Carboxylate-modified microspheres (0.2 
µm, yellow-green fluorescent (505/515), 2 % solids) from Invitrogen (Oregon, USA) were mixed with 
MQ-water, isotonic saline or alginate solutions of G-block DPn 12, G-block DPn 24, G-block DPn 33 and 
LFR 5/60 respectively at a particle concentration of 0.038 %. This nanoparticle-MQ-
water/saline/alginate solution was pipetted into the mucin filled chambers to a final microsphere 
concentration of 0.0025 %, a final alginate concentration of 4.7 mg/mL and a final PG mucin 
concentration 40 mg/mL. Each sample was stirred with the pipette tip after addition of particle solution 
and left overnight in storage at 3 °C. The following day the particles were tracked on a confocal laser 
scanning microscope (CLSM) Leica SP5 from Leica microsystems (Mannheim, Germany). The 
parameters the particles were tracked with are given in Appendix F. The microscope image-series were 
analysed using ImageJ and Matlab. The procedure for image analysis (ImageJ) implements the feature 
point detection and tracking algorithm described by Sbazarini and Koumoutsakos (Sbalzarini and 
Koumoutsakos, 2005) and is given in Appendix G, and the Matlab program was developed by Astrid 
Bjørkøy at the department of physics (NTNU) and is given in Appendix H. 
 
2.2.5 NMR 
Alginate G-block DPn 12, G-block DPn 24 and G-block DPn 33 was mixed with 600 µL 99.9 % D2O from 
Chiron AS (Trondheim, Norway) to a concentration of 0.01 mg/µL in separate NMR-tubes (178 x x4.95 
mm) from Duran® group (Mainz, Germany). To each tube was added 5 µL trimethylsilyl propionate 
(TSP, 1 % solution in D2O) from Aldrich (Milwaukee, USA) and 20 µL triethylenetetraminehexacetic acid 
(TTHA, 0.3 M solution in D2O) from Sigma (St. Louis, USA). TSP was used as a NMR reference (Grasdalen 
et al., 1979) and TTHA was added in order to bind Ca2+ residues (Gaszner et al., 2001) that might 
otherwise influence the NMR data by interacting with the alginate molecules (Grasdalen et al., 1979). 
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The experiments were carried out on a BRUKER Avance DPX 300 equipped with a 5 mm QNP probe. 
The NMR data was processed and analysed with TopSpin 3.0 software. 
 
2.2.6 HPAEC-PAD 
For the quantification of oligomers of alginate high-performance anion-exchange chromatography 
with pulsed amperometric detection (HPAEC-PAD) was used (Ballance et al., 2005). Alginate G-block 
DPn 12, G-block DPn 24 and G-block DPn 33 was mixed with MQ-water to a concentration of 2 mg/mL 
in separate beakers. No internal standard was used since start concentration of alginate G-block was 
already known. However, an external standard was used in order to make a response curve to 
determine molecular weight distribution within each sample (alginate G-block DPn 5.3, produced at 
NTNU). The measurements were carried out on a high performance liquid chromatography (HPLC) 
setup with AS-50 auto sampler, ED-40 electrochemical detector and GP-50 gradient pump from Dionex 
Co. (Sunnyvale, USA). Carbonate free NaOH diluted to 0.1 M from a 50 % (w/v) stock solution was used 
as mobile phase and 1 M analytical grade sodium acetate (NaAc) from Merck (Dermstadt, Germany) in 
0.1 M NaOH as eluent. An AG4A pre column and an IonPac 4x250 AS4A main column was used and 
linear gradients of NaAc were produced by increasing the concentration of eluent from 0 to 87.5 % 
over 90 minutes. Elution velocity was 1 mL/min and the pressure showed 650-750 psi. Chromeleon 6.7 
software was used for instrument control and data analysis. 
 
2.2.7 SEC-MALLS 
The alginate LFR 5/60 sample was mixed with MQ-water to a concentration of 10 mg/mL. The 
measurements were carried out on a LC-10AD pump and a SCL-10A VP auto injector from Shimadzu 
Co. (Kyoto, Japan), a Dawn Heleos II LS-detector and a Optilab T-rEx RI-detector from Wyatt Technology 
Co. (Santa Barbera, USA) and a TSK G-4000 + 3000PWXL column from Toso Haas (Tosoh Bioscience LLC, 
King of Prussia, USA). The SEC-MALLS data was processed and analysed with Astra 6.0 software. 
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3 Results and discussion 
 
3.1 The effect of alginate on bio-similar mucus 
 
The bio-similar mucus developed by COMPACT collaboration partners at the University of Copenhagen, 
Denmark is meant to mimic the rheological properties of porcine intestinal mucus (PIM). It is meant to 
enable viable drug absorption testing in vitro without the need for native PIM (Bøgh et al., 2013). 
Because the bio-similar mucus consists primarily of commercialized mucin it is not limited to intestine 
availability. In order to determine how well the bio-similar mucus mimics PIM in the presence of other 
polymers, the effect of three alginate molecules (alginate G-block DPn 12, alginate G-block DPn 33 and 
alginate LFR 5/60) was investigated on bio-similar mucus and porcine small intestinal mucus (PSIM). 
Isotonic alginate solutions (70 mg/mL) were mixed with bio-similar mucus to a final concentration of 
4.7 mg/mL. The mixture of bio-similar mucus and alginate was properly stirred three times with 10 
minutes intervals, before being applied on the rheometer. Isotonic saline was used as control to 
eliminate changes in ionic strength from adding alginate solution, and to account for any unwanted 
effects due to dilution.  
Bio-similar mucus treated with alginate G-block DPn 12 (G12), alginate G-block DPn 33 (G33) 
and alginate LFR 5/60 (LFR) respectively was rheologically tested through a strain and a frequency 
sweep. Strain sweeps were done initially to determine the position and range of the linear viscoelastic 
area(s) where stress and strain are directly proportional and the moduli values are independent of 
strain (Barnes et al., 1989). Stress and strain values determined from strain sweeps were used as 
parameters in the oscillatory frequency sweeps. Oscillatory frequency sweeps show the dynamic flow 
behaviour of mucus at different time scales. 
First, the bio-similar mucus was treated with alginate G-block DPn 12, and the frequency sweep 
of the treated sample is compared with a frequency sweep of the control sample in Figure 9. Both 
frequency sweeps were performed on the same day with both samples of bio-similar mucus originating 
from the same batch. Both samples show expected mucus behaviour – the bio-similar mucus display 
viscoelastic properties with both solid-like and liquid-like behaviour (Weitz et al., 2007). As the 
frequency increases, so does both the elastic modulus (G’) and the phase angle (δ) values. The elastic 
modulus increases because the bio-similar mucus is an entangled system. At low frequencies, 
entangled polymers have enough time to glide apart and reorganize. At high frequencies, the 
entanglements stretch rather than pull apart causing an increase in elasticity (Sellers et al., 1988). An 
29 | P a g e  
 
increase in phase angle signifies that the bio-similar mucus gel weakens. This can be explained by a 
larger absolute increase in viscous modulus (G’’) values compared to the elastic modulus at higher 
frequency. This means that the system essentially loses energy, despite the increase in elastic modulus. 
As frequency increases, the amount of force (stress) needed to uphold the constant strain increases. 
Increased force entails increased thermal energy inflicted onto the sample. Since the phase angle 
increases, more of this energy is lost than stored within the sample. 
As  Figure 9 shows, the frequency sweeps of the G12 treated sample and the control sample 
seem nearly identical. The small discrepancy towards the end in the elastic modulus values may simply 
arise from individual differences between the samples. Even though the samples originated from the 
same batch of bio-similar mucus, there could still have been differences in mixing or application on the 
rheometer. Literature has established that low molecular weight alginate G-blocks (DPn 10 and DPn 20) 
weaken ex vivo cystic fibrosis (CF) sputum and PG mucin (Draget and Taylor, 2011, Draget, 2011, Taylor 
et al., 2007, Taylor Nordgård and Draget, 2011). The effect of G12 on bio-similar mucus is therefore 
surprising. This shows that the bio-similar mucus does not interact with alginate G-block DPn 12 in the 
same manner as native mucus or purified mucin.  
In order to be certain that the results portrayed in Figure 9 were accurate, two more replicates 
of the bio-similar mucus treated with G12 was tested. The frequency sweeps of the replicates are given 
in Appendix I, and they show that Figure 9 is representative for G12 treated bio-similar mucus. One of 
the replicates did show a slight deviation in elastic modulus values compared to the control sample, 
but the phase angle values remain identical. Since the phase angle corresponds to the ratio of elastic 
and viscous modulus, it means that even though the values of G’ are lower in the treated sample, the 
relationship between the moduli are identical. The deviation in elastic modulus is therefore deemed 
not to be significant. 
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Figure 9. Elastic modulus (G’) and phase angle (δ) values for bio-similar mucus control (saline) sample and bio-similar mucus 
treated with alginate G-block DPn 12 at a concentration of 4.7 mg/mL. Values were collected from frequency sweeps run at 
20 °C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of the bio-similar 
mucus control sample was a constant strain of 1E-3 and 2E-2 Pa start stress, while the parameters of the treated bio-similar 
mucus was a constant strain of 6E-4 and 1E-2 Pa start stress. 
 
The effect of alginate on the bio-similar mucus was then tested using alginate G-block DPn 33. 
The G33 treated sample and a control sample were rheologically tested through strain sweeps and 
consecutive frequency sweeps on the same day. The frequency sweeps are compared in Figure 10 and 
show that the measured parameters of the bio-similar mucus treated with alginate G-block DPn 33 
deviate from the control sample. This is in contrast to G12 treated bio-similar mucus that did not show 
any difference from the control (Figure 9). The curve of both the elastic modulus and the phase angle 
show similar frequency-dependent behaviour as the G12 treated sample, but there is a discrepancy 
between G33 treated and control sample values. G33 has weakened the bio-similar mucus network as 
seen by a drop in G’ values. In addition, there has been an absolute increase in G’’ values leading to 
higher phase angle values over the entire frequency range.  
The bio-similar mucus network does not consist purely of mucin molecules, meaning that this 
effect cannot definitely be ascribed mucin-G-block interactions. The mucin constituent of the bio-
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similar mucus is a commercially available Sigma crude PG mucin that is too heavily degraded to 
singularly form a gel (Kočevar-Nared et al., 1997). Therefore, in order for the bio-similar mucus to form 
a stable gel with rheological profile similar to PIM, polyacrylic acid is mixed into the solution (Bøgh et 
al., 2013). Despite both polymers carrying negative charges, the Sigma crude PG mucin and the 
polyacrylate stabilize gel formation together. This is possible because of the interactive properties of 
mucin molecules, which enables mucin to strongly adhere to polyanions such as alginate and 
polyacrylic acid (Fuongfuchat et al., 1996). Because the bio-similar mucus network is built upon two 
polymers, the effect of G33 is either with the mucin, the polyacrylate or both. Previous research has 
shown that low molecular weight alginate G-blocks have a marked weakening effect on purified PG 
mucin and CF sputum (Taylor Nordgård and Draget, 2011, Draget and Taylor, 2011). Since G12 in this 
case does not show any effect on the bio-similar mucus, the effect of G-blocks are either a result of G-
block-polyacrylate interactions or G-block-polyacrylate/mucin interactions. According to 
thermodynamic law, binary homopolymer mixtures often lead to phase separation (Bates, 1991). For 
the mixing of two solutions to occur spontaneously the Gibbs free energy of mixing (ΔGmix) must be 
negative in value. Gibbs free energy of mixing depends on the entropy (ΔSmix) and the enthalpy (ΔHmix) 
of mixing shown in equation 4, where T is the temperature.  
∆𝐺𝑚𝑖𝑥 = ∆𝐻𝑚𝑖𝑥 − 𝑇∆𝑆𝑚𝑖𝑥   (4)   
For two high molecular weight polymers carrying the same charge, the entropy of mixing is very low 
since the polymers are restricted to particular arrangements defined by molecular interactions, and 
separation is favoured (Smidsrød et al., 2008). Phase separation is highly dependent on the difference 
in degree of polymerization between the two polymers (Bates et al., 1988). If the homopolymers are 
equally large polymers, separation results. However, if the molecular weight of the two molecules is 
widely different, it is not favourable to separate because the entropy of mixing is large. The polyacrylic 
acid used in the bio-similar mucus is a high molecular weight polymer, while G12 are low molecular 
weight molecules in comparison. The difference in Mw between G12 and polyacrylate is thus too large 
to favour separation. The G33 solution, on the other hand, contains higher molecular weight molecules 
than the G12 solution. The HPAEC-PAD experiment showed that G33 contains molecules with up to 61 
monomers, which could explain why G33 affects the bio-similar mucus and G12 does not. Because the 
amount of alginate solution in the bio-similar mucus is under 10 % of the mucus volume, it is likely that 
the G33 solution upon separation will be dispersed throughout the bio-similar mucus without mixing. 
This will increase the liquid-like properties of the bio-similar mucus, which will cause the appearance 
of a weaker gel with lowered G’ values and higher δ values. 
32 | P a g e  
 
Frequency (Hz)
0,001 0,01 0,1 1 10 100
G
' (
P
a
)
0
10
20
30
40
50
 (
°)
0
10
20
30
40
G' Control
G' G-block DP33
 Control
 G-block DP33
 
Figure 10. Elastic modulus (G’) and phase angle (δ) values for bio-similar mucus control (saline) sample and bio-similar mucus 
treated with alginate G-block DPn 33 at a concentration of 4.7 mg/mL. Values were collected from frequency sweeps run at 
20 °C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of the bio-similar 
mucus control sample was a constant strain of 5E-4 and 1E-2 Pa start stress, while the parameters of the treated bio-similar 
mucus was a constant strain of 1E-3 and 1E-2 Pa start stress. 
 
The bio-similar mucus was further rheologically tested with alginate LFR 5/60. The frequency 
sweep of the LFR treated bio-similar mucus is compared with a frequency sweep of a control sample 
tested on the same day in Figure 11. There is one phase angle value at low frequency for both the 
treated and the control sample that is out of place. This could be because of slip or air bubbles in the 
sample, but because the skip in value happens to both the control and the treated sample, it might 
also be because of batch instability for that particular batch. In any case, it does not influence the rest 
of the frequency sweep, and can be disregarded. 
Apart from this the curves of both the LFR treated sample and the control sample behave as 
expected and the flow profile matches that of the other alginate treated bio-similar mucus samples. 
The difference between the LFR treated sample and the control sample is similar to the effect of G33 
(Figure 10), but the discrepancy between the treated sample and the control is slightly larger for the 
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LFR. This supports the idea that alterations in rheology are a result of phase separation. Alginate LFR 
5/60 has a higher degree of polymerization (DPn ~63) than alginate G-block DPn 33, and should 
theoretically cause a larger degree of separation (Bates et al., 1988). However, the difference in bio-
similar mucus gel weakening between G33 and LFR is not as large as anticipated due to the large 
difference in DPn. The reason could be that the alginate solutions were added to the bio-similar mucus 
per volume, instead of by number of molecules. This means that there are fewer LFR molecules in the 
bio-similar mucus compared to both G33 and G12, which in extension means that the separation effect 
would not necessarily be larger. In addition, the mucin constituent of the bio-similar mucus can also 
interact with the alginate molecules, which means that the effect of alginate cannot fully be ascribed 
alginate-polyacrylate interactions. Because the effect of LFR is less than anticipated compared to the 
effect of G33, it could mean that the mucin glycoproteins play an important interactive role as well. 
This means that the observations are most likely due to interactions between alginate and both mucin 
and polyacrylate, which makes the bio-similar mucus act differently to the presence of alginate 
compared with what is expected for natural mucus samples (Draget and Taylor, 2011, Taylor Nordgård 
and Draget, 2011).  
Rheological experiments performed on LFR treated bio-similar mucus were also done in 
replicates. The replicates show identical response to LFR treatment, and only one of the frequency 
sweeps are given. Such reproducible results suggest that the bio-similar mucus is a stable gel that 
behaves consistently under mechanical deformation. The major differences in the bio-similar mucus 
rheological behaviour arises from batch variations. The reader might have noticed that the control 
sample values are not identical between Figure 9, 10 and 11. The procedure for every experiment has 
been identical, the only difference being the batch and the day the experiment was done.  
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Figure 11. Elastic modulus (G’) and phase angle (δ) values for bio-similar mucus control (saline) sample and bio-similar mucus 
treated with alginate LFR 5/60 at a concentration of 4.7 mg/mL. Values were collected from frequency sweeps run at 20 °C 
from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of the bio-similar mucus 
control sample was a constant strain of 6E-4 and 1E-2 Pa start stress, while the parameters of the treated bio-similar mucus 
was a constant strain of 8E-4 and 1E-2 Pa start stress. 
 
 
3.2 The effect of alginate on native porcine small intestinal mucus 
 
The effect of alginate on porcine small intestinal mucus (PSIM) was tested using the same three 
alginate molecules (G12, G33 and LFR) as with the bio-similar mucus to better compare the samples. 
The rheology of all samples was investigated through strain sweeps and frequency sweeps. The strain 
sweeps were only performed to find where the values of stress and strain were proportional and where 
the moduli values are independent of strain. As with the bio-similar mucus, isotonic saline mixed with 
PSIM was used as control sample to eliminate the change in ionic strength from adding alginate, and 
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to account for any unwanted effects due to dilution. The mixing regime was identical to the bio-similar 
mucus, as was the final concentration of alginate (4.7 mg/mL). The PSIM samples treated with alginate 
solutions were all tested in two replicates, while the control sample was tested in four replicates. 
A frequency sweep of both replicates of PSIM treated with G12 compared with separate 
control samples are given in Figure 12. One of the replicates of treated PSIM had elevated G’ values, 
while the other one had lowered G’ values compared to the control samples. Based on previous 
rheological experiments using low molecular weight alginate G-blocks (DPn 10 and DPn 19/20) on both 
purified PG mucin and ex vivo CF sputum (Taylor et al., 2007, Draget, 2011, Taylor Nordgård and Draget, 
2011, Draget and Taylor, 2011), the elastic modulus of the treated PSIM was expected to be lower than 
the control sample. Treatment of G-block on CF sputum and PG mucin were found to weaken the gel, 
with increased phase angle values and decreased elastic/loss modulus values compared to untreated 
samples.  
In Figure 12, the difference in G’ values between the two replicates is most likely due to the 
inherent variations within the native mucus. Native mucus contains various proteins, ions and 
lipids/surfactants that creates a chemically diverse and complex solution (Bansil and Turner, 2006). In 
addition, the PSIM samples are inhomogeneous and the substances native to PSIM can exist in varying 
amounts throughout the same batch. Because of this, the beaker which contained the frozen PSIM 
was stirred in order to achieve a more homogeneous mixture before the desired amount of PSIM was 
measured out. Despite this, food debris and other inhomogeneities could be seen when the PSIM 
samples were applied on the rheometer. Even though the elastic modulus values are contradictory, 
the phase angle values in both cases are higher for the treated sample. This means that the amount of 
energy stored within the gel structure of PSIM differs, but that in both cases G12 has weakened the 
mucus gel. Thus, introducing alginate G-block DPn 12 into the PSIM matrix increases the ratio between 
G’’ and G’, giving the gel relatively more liquid-like properties. 
Literature reports that there exist large inter- and intra-species variations in porcine intestinal 
mucus elastic properties (Boegh et al.). G’ variations have been seen in CF sputum as well, but the ratio 
between G’’ and G’ vary little (Sanders et al., 2000), meaning that the phase angle values are generally 
more representative for mucus rheology in highly complex mixtures such as native mucus. 
Experimental data from the four control replicates show the same as literature; G’ varies between 
experiments, but the ratio between G’’ and G’ remains the same giving little variations in phase angle 
values. The G’ and δ values from the four control samples are compared in Figure 13. 
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Figure 12. Elastic modulus (G’) and phase angle (δ) values of two replicates of porcine small intestinal mucus (PSIM) treated 
with alginate G-block DPn 12 compared with two replicates of PSIM control (saline). Concentration of alginate was 4.7 mg/mL. 
Values were collected from frequency sweeps run at 20 °C from low to high frequency with cone dimension C 40 4 ETC. For the 
left replicate, the parameters of the frequency sweep of the PSIM control was a constant strain of 1E-3 and 1E-2 Pa start 
stress, while the parameters of the treated PSIM was a constant strain of 1E-3 and 1E-2 Pa start stress. For the right replicate, 
the parameters of the frequency sweep of the PSIM control was a constant strain of 6E-4 and 2E-2 Pa start stress, while the 
parameters of the treated PSIM was a constant strain of 6E-4 and 1E-2 Pa start stress. 
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Figure 13. Elastic modulus (G’, left graph) and phase angle (δ, right graph) values of four replicates of porcine small intestinal 
mucus (PSIM) control (saline) sample compared. Values were collected from frequency sweeps run at 20 °C from low to high 
frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of replicate 4 was a constant strain of 6E-
4 and 2E-2 Pa start stress, while the parameters of all the other replicates were a constant strain of 1E-3 and 1E-2 Pa start 
stress. 
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Figure 14 shows a frequency sweep of the G33 treated PSIM sample compared with a 
frequency sweep of a control. The parameters of the frequency sweep were based on an initial strain 
sweep not shown here. Alginate G-block DPn 33 appears to have strengthened the mucus gel slightly. 
The values of G’ are elevated compared to the control sample, and the values of δ are slightly lower. 
According to Figure 13 and literature (Sanders et al., 2000, Boegh et al.), the G’ values vary too much 
within mucus to be able to conclude anything, but the δ values are still indicative. Therefore, the slight 
decrease in phase angle values between the G33 treated sample and the control sample indicates that 
G33 increase elastic properties more than liquid-like properties. Alginates have been shown to be able 
to interact with mucin molecules through electrostatic interactions (Taylor et al., 2005b), and that low 
molecular weight G-blocks weaken the mucin gels by decreasing the cross-linking density between 
mucin molecules through competitive inhibition (Taylor Nordgård and Draget, 2011). Based on this, it 
would seem that the chain length distribution in the G33 solution contains alginate G-block molecules 
long enough with large enough radius of gyration and persistence length to induce a higher cross-
linking density compared to PSIM mixed with saline.  
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Figure 14. Elastic modulus (G’) and phase angle (δ) values for porcine small intestinal mucus (PSIM) treated with alginate G-
block DPn 33 compared with PSIM control (saline). The concentration of alginate was 4.7 mg/mL. Values were collected from 
frequency sweeps run at 20 °C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency 
sweep for the PSIM control was a constant strain of 1E-3 and 1E-2 Pa start stress, while the parameters for treated PSIM was 
a constant strain of 1E-3 and 1E-2 Pa start stress. 
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Figure 15 shows the frequency sweep of PSIM treated with alginate LFR 5/60 and PSIM control 
compared. Alginate LFR 5/60 have a more defined strengthening effect on PSIM than G33. The elastic 
modulus values are almost twice as high for LFR treated PSIM, indicating a clear increase in stored 
energy within the sample. In addition, phase angle values are lower than the control sample, meaning 
that the elastic properties of PSIM has increased more than the viscous properties upon addition of 
alginate LFR 5/60. LFR are higher molecular weight (Mw) molecules than any of the G-blocks, which can 
more readily cross-link to mucin molecules through electrostatic interactions (Taylor et al., 2005b) due 
to longer chain lengths. 
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Figure 15. Elastic modulus (G’) and phase angle (δ) values for porcine small intestinal mucus (PSIM) treated with alginate LFR 
5/60 compared with PSIM control (saline). The concentration of alginate was 4.7 mg/mL. Values were collected from frequency 
sweeps run at 20 °C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep for 
the PSIM control was a constant strain of 1E-3 and 1E-2 Pa start stress, while the parameters for treated PSIM was a constant 
strain of 1E-3 and 1E-2 Pa start stress. 
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Compared to the bio-similar mucus experiments, the elastic modulus values of PSIM generally 
have a steeper slope, and the phase angle values vary less with frequency. The elastic modulus curves 
are steeper most likely because PSIM is more complex and diverse than the bio-similar mucus. 
Mortazavi et al. (Mortazavi et al., 1993) investigated the properties of mucin-polyacrylate gels and 
found evidence that it is both an entangled and a weakly cross-linked system. Cross-linking happens 
mainly through hydrogen bonding between the polyacrylate molecules and the mucin carbohydrate 
moieties (Patel et al., 2003). For a purely chemically cross-linked gel, the elastic and viscous modulus 
would be independent of frequency of oscillation, while the slope for G’ and G’’ values would increase 
with increased frequency for physically entangled systems (Ross-Murphy and McEvoy, 1986). This is 
because the physically entangled subunits glide apart at low frequencies, but as frequency increases 
the entangled polymer chains are not given time to gently glide apart and will instead stretch which 
increases elasticity. Both PSIM and the bio-similar mucus are both entangled and cross-linked gels, but 
the reason that the G’ curve is steeper for native PSIM over the range of frequency could be that there 
exist a more extensive entangled network of mucin polymers than of mucin-polyacrylate or because 
the bio-similar mucus is less cross-linked. The degree of entanglements depend on the concentration 
of mucin, the length of mucin subunits and the chemical nature of the mucin molecules (Thornton and 
Sheehan, 2004). Less than 1 % of the bio-similar mucus consisted of polyacrylic acid and 5 % were 
Sigma crude mucin. The concentration of mucin in PSIM was not tested, but it could potentially have 
been higher. In addition, the length of mucin subunits in the native mucus sample would be expected 
to be longer since the commercial mucin is heavily degraded (Kočevar-Nared et al., 1997). The native 
mucus is also expected to exhibit a more diverse chemical nature because of other inherent substances 
in mucus. The native mucus sample might also possess several more interaction sites on its mucin 
constituents due to the purification method of Sigma mucin which often causes cleavage of 
hydrophobic domains on the protein backbone (Davies and Viney, 1998), but also because of the 
polyacrylate that only interact through electrostatic interactions and hydrogen bonding. 
The phase angle values for PSIM are more stable than the bio-similar mucus ones. This means 
that the viscous modulus of the bio-similar mucus increases more relative to the elastic modulus as 
frequency increases. In other words, more energy is lost in the bio-similar mucus than in the PSIM. This 
could be a consequence of the lubricating ability of mucus. Under increasing shear rate, the mucus 
creates a slippage plane (Cone, 2009), which causes very little of the energy introduced into the sample 
to be lost through frictional forces. However, even though the Sigma mucin molecules are degraded, 
the bottle brush structure of the mucin molecules remain mostly intact (Davies and Viney, 1998), and 
the experiments are performed within the linear viscoelastic area, meaning the shear rate that could 
cause a slippage plane should not increase. The behaviour of bio-similar mucus was investigated by 
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Frida (Våset, 2014), who found that the behaviour was independent of stress and strain (i.e. the phase 
angle increased abruptly at higher frequencies in both stress-controlled and strain-controlled 
experiments). It is unclear what could have caused this. 
Even though the bio-similar mucus forms a rheologically stable gel with similar profile to PSIM, 
it does not mimic the dynamic behaviour of PSIM in the presence of other polymers with negative 
charge. Only alginate has been investigated here, but based on thermodynamic laws, the observed 
effect is expected in other binary homopolymer mixtures as well (Smidsrød et al., 2008). The difference 
between the effects of alginate on PSIM and the bio-similar mucus is most likely because of the 
differences in structure between mucin and polyacrylate. Granted, both mucus samples form 
entangled gels with some degree of weak cross-linking, but the mucin molecules display a larger pool 
of different interactions and shows signs of being more extensively entangled. The polyacrylate is 
negatively charged, and interact by electrostatic interactions and hydrogen bonding, whereas mucin 
molecules interact by hydrophobic and Van der Waals interactions in addition to the aforementioned 
interactions for polyacrylic acid (Woodley, 2001). In addition, the mucin molecules contain positively 
charged regions in addition to negative ones (close to the cysteine-rich domains which are cleaved in 
the commercialized mucin sample), arising from amino acids on the protein backbone of mucin 
molecules (lysine, arginine and histidine) (Taylor Nordgård and Draget, 2011). These charges might 
cause the alginate molecules to stay in the solution and bind to mucin through electrostatic adhesion 
instead of separating into another phase as is the case in the bio-similar mucus. 
 
 
3.3 The effect of alginate on purified porcine gastric mucin 
 
Purified porcine gastric (PG) mucin can be used as a model system for human tracheobronchial mucus, 
because of similar gene products in the gastrointestinal mucus compared with the tracheobronchial 
mucus (Van Klinken et al., 1995), and because porcine and human mucus are structurally related 
(Turner et al., 1999). It is therefore interesting to investigate the effect of alginate on PG mucin. Here, 
the effect of four different alginate molecules are studied – alginate G-block DPn 12 (G12), alginate G-
block DPn 24 (G24), alginate G-block DPn 33 (G33) and alginate LFR 5/60 (LFR). Two different lots of PG 
mucin has been used in this thesis. The samples are denoted lot#1 and lot#2 respectively. 
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PG mucin lot#1 was rehydrated in MQ-water at a concentration of 40 mg/mL, and was stored 
at 3 °C for 48 hours with gentle stirring. Because the aim of this thesis is to translate the findings into 
human benefit, the desired pH was physiological pH 7.4. The rehydrated PG mucin had ambient pH 
4.6, and 10 mM HEPES buffer (buffer range 6.8-8.2) was added to the solution to prevent the pH from 
getting too high during titration. After HEPES addition, the pH was 5.2 and the PG mucin solution was 
visibly thinner. A small part of the sample was transferred to a separate beaker and pH reduced to 3.7, 
which visibly thickened the solution. A sample from each solution of pH 3.7, 4.7 and 5.2 was applied 
on the rheometer and their flow properties studied. The sample at pH 3.7 and 4.7 was tested through 
frequency sweeps with stress and strain values determined via initial strain sweeps. The sample at pH 
5.2 was only tested through one frequency sweep due to noticeably lower viscosity than the other 
samples. Flow properties of very liquid samples are hard to measure using oscillatory rheology, which 
are best suited at measuring viscoelastic solids (gels) (Barnes et al., 1989). Liquid samples often 
generate a high degree of noise because of low material response, which is why predetermined stress 
and strain values were used for the sample at pH 5.2. 
Values from the three frequency sweeps of PG mucin at pH 3.7, 4.7 and 5.2 are depicted in 
Figure 16. Three of the graphs show the elastic (G’) and viscous (G’’) modulus of each sample 
separately, while the fourth graph shows the phase angle values from all samples compared. The PG 
mucin sample at pH 3.7 has a flow profile close to what is expected of a viscoelastic solid. Elastic 
modulus is higher than the viscous modulus over the entire frequency range. This leads to phase angle 
values between 0 ° and 45 °. The other two samples display liquid-dominant properties, with G’’ being 
higher than G’ most of the frequency sweep and phase angle values mostly above 45 °. These signs 
indicate that PG mucin at pH 4.7 and 5.2 behave like an elastic liquid rather than a viscoelastic solid 
(Weitz et al., 2007). However, even though the PG mucin at 4.7 and 5.2 are elastic liquids, they are still 
entangled systems and the G’ and G’’ increase with increasing frequency of oscillation. At low 
frequencies, the liquid character of the sample is apparent, and there is no resistance to the 
deformation. At higher frequency more of the thermal energy used to induce the constant strain is 
being stored than lost because the entangled molecules resist the deformation, leading to a decrease 
in phase angle values. This is opposite to viscoelastic solids where more energy dissipates than is being 
stored at high frequency.  
The results from Figure 16 indicate that PG mucin rheology is pH dependent. This behaviour 
has not been seen for PG mucin received at the Rheodor laboratory before (Nordgård, 2014), and the 
behaviour suggests some structural change between pH 3.7-4.7. Based on literature, mucin molecules 
are negatively charged glycoproteins (Cone, 2009). Some of these negative charges arise from 
negatively charged amino acids (glutamic acid and aspartic acid) located on the protein backbone with 
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pKa values around 4 (Cao et al., 1999). At pH under 4 these carboxyl groups protonate, which leads to 
a reduction in electrostatic interactions between mucin molecules and an increase in hydrogen 
bonding. In addition, the conformational change is thought to expose hydrophobic regions located on 
the protein backbone of mucin (Lee et al., 2005). These regions were previously unable to interact due 
to electrostatic repulsion, but as some repulsion ceases there will be an increase in hydrophobic 
interactions between such exposed regions. The resulting conformational changes strengthens the gel 
under pH 4, which is imperative for gastric mucus to prevent acid from reaching the epithelial surface 
(Celli et al., 2005).  
According to the observations, the PG mucin sample is not a gel at pH over 4. This is 
contradictory to native mucus, where it is a gel at physiological pH as well as pH under 4. Another 
influential factor could therefore be that ionic strength affected PG mucin rheology, since HCl/NaOH 
was added to lower/elevate pH. However, if the observations were a consequence of ionic strength, 
the PG mucin sample should not have gelled when the pH was reverted to 3.7 after being 5.2, since it 
has been reported that high ionic strength decreases PG mucin viscosity (Bhaskar et al., 1991). The 
ionic effect could still have been a factor, but it was not the sole reason for the sol-gel transition. 
As a result of low material response of the PG mucin sample at pH 5.2, the frequency sweep is 
crowded by noise. Noise appears due to low mechanical resistance in the sample (i.e. low material 
response), which leads to minimal rotational forces (torque values). Low material response causes 
inaccuracies in the measured values, which is why some values of G’ and G’’ at low frequencies from 
the frequency sweep of the PG mucin sample at pH 5.2 were omitted from Figure 16. 
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Figure 16. Elastic modulus (G’), viscous modulus (G’’) and phase angle (δ) values of untreated porcine gastric (PG) mucin at 
three different pH values. The concentration of PG mucin was in all cases 40 mg/mL. All values depicted were collected from 
frequency sweeps at 20 °C from low to high frequency. Upper left graph shows G’ and G’’ values of PG mucin at pH 3.7 
measured at constant strain 2E-1 and 1 Pa start stress with cone dimension C 40 1 ETC. Upper right graph shows G’ and G’’ 
values of PG mucin at pH 4.7 measured at constant strain 2E-1 and 1.7E-1 Pa start stress with cone dimension C 40 1 ETC. 
Lower left graph shows G’ and G’’ values of PG mucin at pH 5.2 measured at constant strain 5E-2 and 3E-3 Pa start stress with 
cone dimension C 50 1 ETC. Lower right graph show the δ values of the three samples compared. 
 
The pH dependence was a minor setback for further experimentation, partly because 
physiological pH is 7.4, but also because alginate protonates at low pH and would precipitate out of 
the solution (Stanford, 1886). There are always considerations to make regarding translation of results 
from animal material experimentations to human use (Watkins et al., 2010), and even if the 
experiments were performed at low pH, the results could still be used as a foundation for further tests. 
However, if alginate does not maintain its structure and function, then realizing the aim of this thesis 
will not be feasible. PG mucin lot#2 did not show pH instabilities to the same degree as lot#1, but 
because there were minor variations, the PG mucin solution was left at ambient pH of 4.5. Since 
temperature also proved to influence rheology, all frequency sweeps of PG mucin samples were done 
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at 10 °C. PG mucin lot#2 was rehydrated in MQ-water in the same manner as lot#1 (48 hours, 3 °C, 
gentle stirring) at a concentration of 42.84 mg/mL (to achieve a final concentration of 40 mg/mL after 
addition of alginate/saline). Isotonic saline was used as control as with PSIM and the bio-similar mucus 
in order to prevent ionic strength differences between treated and untreated PG mucin, and to 
account for dilution effects. Freshly made samples were quickly measured into small Eppendorf tubes 
and frozen because hydration time proved to be a significant factor for PG mucin rheology. 
The effect of alginate on PG mucin lot#2 was tested using G12, G24, G33 and LFR at a 
concentration of 4.7 mg/mL. Each sample was subjected to four frequency sweeps at four different 
strains (5E-4, 1E-3, 5E-3 and 1E-2) and one strain sweep. Exposing the samples to four different strains 
was thought to show the dynamic properties of PG mucin better than just one frequency sweep; it 
shows how the treated samples behave under increasing deformation. Unlike the previous 
experiments with PSIM and the bio-similar mucus, the strain sweep was done last in the series of 
sweeps. This was to prevent the samples from being subjected to unnecessary high deformation prior 
to the frequency sweeps. 
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Figure 17. Elastic modulus (G’ and phase angle (δ) values of porcine gastric (PG) mucin control (saline) and PG mucin treated 
with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 at 1Hz frequency over 
four different values of strain. Concentration of alginate was 4.7 mg/mL and concentration of PG mucin was 40 mg/mL. All 
values were collected from frequency sweeps run at 10 °C from low to high frequency with cone dimension C 40 1 ETC. 
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Complete frequency sweeps for all samples at 5E-4 and 1E-3 strain is given in Figure 18 and Figure 19 respectively, and 
complete frequency sweeps for all samples at 5E-3 and 1E-2 strain is given in Appendix J. 
Figure 17 shows elastic modulus and phase angle values for all samples over all strains at 1 Hz 
frequency compared. PG mucin control sample has the highest G’ values at 5E-4 and 1E-3 strain 
followed by G33 treated PG mucin. The other mucin samples have very low values of G’ at 1 Hz 
frequency over all four strains. This suggests that G12, G24, G33 and LFR treatment of PG mucin 
decreased amount of stored energy within the mucin matrix, indicating that the gel weakened. As 
mentioned earlier, the effect of low molecular weight alginate G-blocks (DPn 10 and DPn 19/20) have 
been tested on ex vivo CF sputum and PG mucin (Draget and Taylor, 2011, Taylor et al., 2007, Taylor 
Nordgård and Draget, 2011). Both were found to have a weakening effect, and it is therefore not 
surprising that G12 and G24 show a high degree of gel weakening. It was found that G-block DPn 10 
had a more profound weakening effect on mucus structure than G-block DPn 19 (Taylor Nordgård and 
Draget, 2011), and that the effect of G-block DPn 19 on CF sputum samples varied compared to the 
control (saline). In this case, G12 and G24 treatment seems to have exactly the same effect. However, 
according to Figure 18 and 19 showing the full frequency sweeps of all the samples compared at 5E-4 
and 1E-3 strain respectively, the G12 treated sample suffered from a high degree of noise (frequency 
sweeps at 5E-3 and 1E-2 strain is given in Appendix J). The similarities between G12 and G24 treatment 
may therefore not be significant. The G33 treated PG mucin exhibit a stronger gel than G12 and G24, 
which is logical based on the previous findings regarding G-block DPn 10 and G-block DPn 19 (Taylor 
Nordgård and Draget, 2011). G33 molecules have a higher degree of polymerization in general with 
larger radius of gyration and persistence length, meaning that the G33 cross-link between mucin 
subunits more than the lower molecular weight counterparts. 
The phase angle values for all the alginate treated samples seem to be similar in Figure 17 
(disregard the δ values for G12 treated PG mucin at 5E-4 and 1E-3 strain due to noise). This means that 
even though the G’ values indicate a gel weakening, the phase angle values does not. Apparently, all 
PG mucin samples seem to have almost equal amounts of liquid-like and solid-like properties at 5E-4 
and 1E-3 strain. This is because G’’ decrease by a factor equal to the decrease in G’, causing the phase 
angle values to remain the same in both alginate and saline treated samples. At higher strain, the δ 
values for the control sample increases, but the alginate treated values remain similar. This is surprising 
compared to literature documenting different rheological effects of different molecular weight 
alginates on PG mucin (Draget and Taylor, 2011, Taylor et al., 2005a, Taylor et al., 2007, Taylor et al., 
2005b, Taylor Nordgård and Draget, 2011). However, torque values from each experiment was very 
low (data not shown), indicating low mechanical response which could explain some of these surprising 
findings. 
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Figure 18. Elastic modulus (G’, left graph) and phase angle (δ, right graph) values for porcine gastric (PG) mucin control (saline) 
and PG mucin treated with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 
compared. All values are from frequency sweeps at 10 °C from low to high frequency with constant strain 5E-4 and 1E-2 Pa 
start stress. Cone dimension was C 40 1 ETC. Concentration of PG mucin in MQ-water was 40 mg/mL and concentration of 
alginate was 4.7 mg/mL. 
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Figure 19. Elastic modulus (G’, left graph) and phase angle (δ, right graph) values for porcine gastric (PG) mucin control (saline) 
and PG mucin treated with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 
compared. All values are from frequency sweeps at 10 °C from low to high frequency with constant strain 1E-3 and 1E-2 Pa 
start stress. Cone dimension was C 40 1 ETC. Concentration of PG mucin in MQ-water was 40 mg/mL and concentration of 
alginate was 4.7 mg/mL. 
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Figure 20. The effect of differently sized G-rich alginate molecules on mucus/mucin gel strength based on experiments with 
porcine small intestinal mucus (PSIM) and literature (Taylor et al., 2005a, Taylor Nordgård and Draget, 2011). An area where 
the gel strength of untreated mucin/mucus is thought to be is also given. 
 
Assuming that the elastic modulus values in Figure 17 are correct despite the low torque 
values, LFR treatment causes equal amounts of lost energy as G12 and G24 treatment compared to 
the control. Based on literature (Taylor et al., 2005a, Taylor Nordgård and Draget, 2011) and on the 
results obtained from the PSIM experiments, the relationship between gel strength and molecular 
weight of G-rich alginates follows the graph in Figure 20. The concentration of alginate solution in PG 
mucin is exactly the same as in PSIM, and alginate should consequently have a similar effect on PG 
mucin. A possible explanation could be that some of the inherent substances of PSIM associated with 
LFR molecules, which increased gel strength. For instance, mucus secretions contain divalent calcium 
ions (Ca2+), seemingly an important feature for mucin interactions (Perez-Vilar, 2007). Alginates high 
in guluronate gel in the presence of divalent cations, and they have an especially high affinity for Ca2+ 
(Pawar and Edgar, 2012). It is therefore possible that LFR gels within PSIM due to residual Ca2+ or even 
mucin bound Ca2+, which strengthens the gel (Fuongfuchat et al., 1996). Low molecular weight G-blocks 
on the other hand would react differently because they consist almost entirely of G-residues. This 
means that if the G-residues bind calcium there would be nothing to keep the molecules in solution, 
and the G-blocks would precipitate out (Skják-Bræk et al., 1986). The effect of G12 on PSIM could 
therefore be due to G12 precipitation which increases liquid-like properties or because of G12 
incorporation into the mucin network which decreases the cross-linking density. Based on the 
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observed effect of G33, the most likely scenario is that the G-block molecules incorporate into the 
mucin structure because precipitation of G33 would not cause a strengthening effect seen in Figure 
14Figure. However, the LFR molecules has a fraction of M-residues (FM) equal to 0.31 and will stay in 
solution after gelling. In the PG mucin sample there does not exist a significant population of calcium 
ions, meaning that alginate gelling is not a factor when considering the effect of alginate. The observed 
effect will purely depend on alginate-mucin interactions, which could explain the large difference in 
LFR effect. However, LFR should still be able to increase cross-linking density in PG mucin samples due 
to a high degree of polymerization, and the results are therefore unexpected. Another possibility is 
that the dilution effect could have been more profound for the LFR sample. All alginate solutions were 
added per volume to a final concentration of 4.7 mg/mL, but because of differences in molecular 
weight, there would be more molecules of the shorter G-blocks in the mucus/mucin solution compared 
to LFR. 
According to Figure 17, the samples mostly show expected behaviour as deformation 
increases. As the deformation increases, the increased strain on the sample causes the non-covalent, 
low-affinity bonds keeping the mucin gel together to break. This leads to lower elastic modulus values 
because the energy contained within the bonds dissipates. The phase angle values similarly increase 
because the ratio of G’’ and G’ increase, meaning the samples show relatively more liquid-like 
properties. The G’ values for the G12, G24 and LFR treated sample do not follow the expectations. It is 
likely that the response of the samples are too low to achieve high enough signal to noise ratios for 
accurate measurements. However, the phase angle values conform to the theory more than the G’ 
values. In every sample except for the G12 treated one, the phase angle values increase with increasing 
strain. Both G’ and G’’ decrease at higher strain, but G’’ values decrease less relative to G’ giving rise 
to higher phase angle values.  
Another interesting point to make is that PG mucin control sample seems to be less resistant 
to deformation. According to the strain sweeps that were done with all samples, the control showed a 
steeper downward slope than all the treated samples as the strain increased. Although the data from 
the strain sweeps are not given here, it still becomes apparent from Figure 17 where the G’ and δ 
values for the control sample change more drastically between the frequency sweeps at different 
strains. Studies has shown that muco-adhesive polymers generally stabilize the mucus gel, increasing 
the resistance to deformation through an act of synergism (Madsen et al., 1998b). This has been 
ascribed interactions between mucin and the muco-adhesive polymer in the form of non-covalent 
bonding (hydrogen bonds, electrostatic interactions) (Madsen et al., 1998a).  
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As mentioned, the effect of alginate LFR 5/60 on PG mucin was surprising compared to the 
observed effect of LFR on PSIM (depicted in Figure 20). It was therefore decided to perform another 
frequency sweep with a new sample of PG mucin treated with LFR. The replicate showed even lower 
values of G’ than before (data not shown). In order to validate that the results were not a consequence 
of the duration of freezing, two PG mucin control samples were rheologically tested since the control 
showed higher response than the other treated samples. One of the samples were from the original 
rehydrated batch of PG mucin, while the other were from a second batch that had been frozen for a 
shorter period of time. The frequency sweeps of both replicates are given in Figure 21 at constant 
strain 1E-3. There is a clear discrepancy between the initial control sample and these replicates. Both 
replicates in Figure 21, although not equal, have values of G’ under 10 Pa, while the initial control 
sample had G’ values between 20 and 40 Pa (Figure 19). Based on these findings it was hypothesized 
that the act of freezing might disrupt the PG mucin network, not the length of subzero storage. If this 
were to be true, the only possible explanation would be that water upon solidification forms ice 
crystals that could physically damage the mucin latticework in different degrees depending on the 
amount of crystals formed. There are disagreements in literature regarding the effect of freezing on 
mucus samples. One research group determined that freezing of CF sputum samples did not have any 
significant effect (p < 0.05) on G’ and G’’ values (Sanders et al., 2000), while other groups have found 
that freezing markedly lowered G’ values for gastrointestinal mucus (Bøgh et al., 2013, Bell et al., 1984, 
Boegh et al.) presumably due to ice crystal formation. Here, the effect of freezing could have been 
more profound because the PG mucin was frozen in small Eppendorf tubes, which could have been a 
contributing factor to increased disruption due to ice crystal formation. 
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Figure 21. Elastic modulus (G’) and phase angle (δ) values of two replicates of porcine gastric (PG) mucin control (saline) 
sample. Concentration of PG mucin in MQ-water was 40 mg/mL. Values for both graphs are from frequency sweeps at 10°C 
from low to high frequency with constant strain 1E-3 and 1E-2 Pa start stress. Cone dimension was C 40 1 ETC. The sample to 
the left is from the first batch of rehydrated PG mucin that had been frozen 55 days, while the sample to the right is from the 
second batch of rehydrated PG mucin that had been frozen for 24 days. 
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Figure 22. Elastic modulus (G’) and phase angle (δ) values of porcine gastric (PG) mucin control (saline) and PG mucin treated 
with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 compared. The 
concentration of PG mucin in MQ-water was 40 mg/mL and the concentration of alginate was 4.7 mg/mL. All values are 
collected from frequency sweeps at 10 °C from low to high frequency at constant strain 1E-3 and 1E-2 Pa start stress. Cone 
dimension was C 40 1 ETC. 
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In order to eliminate the potential freezing issue, it was decided to redo frequency sweeps at 
1E-3 strain on freshly rehydrated PG mucin control sample and PG mucin treated with alginates. The 
new batch of PG mucin was hydrated for 72 hours in storage at 3 °C with gentle stirring. Concentration 
of PG-mucin in MQ-water was 42.84 mg/mL (to achieve a final concentration of 40 mg/mL after 
addition of alginate/saline). This batch was left to hydrate for a longer period of time under the 
assumption that the observed rheological impact of hydration time on PG mucin rheology would 
diminish over time. Therefore, because the samples were going to be tested on the same day, with 5 
hours separating the first and last experiment, the new batch of PG mucin was left to hydrate 24 hours 
longer than before. 
Figure 22 shows elastic modulus and phase angle values from frequency sweeps of the freshly 
rehydrated PG mucin treated with various alginate molecules and the PG mucin control sample 
compared. This time, the G12 treated PG mucin has the highest elastic modulus values. The G33 
treated sample has the lowest, while the remaining samples are bundled together in between the 
extremes. These results are puzzling, and do not coincide with previous findings or literature (Draget 
and Taylor, 2011, Draget, 2011, Taylor et al., 2007, Taylor et al., 2005b, Taylor Nordgård and Draget, 
2011). The phase angle values for all samples do not provide more clarity. The graph is crowded with 
noise, and there is a larger difference between the samples than before (Figure 19). As mentioned 
earlier the elastic modulus values of mucus samples can vary greatly between replicates of mucus 
(Boegh et al., Sanders et al., 2000). However, this sample contains only mucin molecules without the 
other inherent substances of mucus. PG mucin is therefore not as inhomogeneous as native mucus, 
and should in theory have more stable values of G’. A possible explanation for the observed 
inconsistencies is that the PG mucin lot#2 suffered from instabilities greater than first anticipated. The 
response from the sample was low in every experiment with torque values between 1E-7 and 1E-8 Nm. 
These were very low values compared to the other native mucus samples which had torque values 
between one and two decades higher, meaning that in every experiment with PG mucin the signal to 
noise ratio was extremely low. This could have led to the observed differences in elastic modulus and 
phase angle values between replicates. The reason might be that the purification method of PG mucin 
unintentionally degraded the mucin molecules. Another reason could be the small observed changes 
in pH between batches. 
Supporting information that the signal to noise ratio in PG mucin samples was very low, is given 
by comparing Lissajous data from PG mucin and PSIM in Figure 23. Lissajous plot shows the relationship 
between stress and strain, which should follow an elliptic curve since PG mucin is a viscoelastic material 
(Deshpande et al., 2010). Figure 23 shows the Lissajous plot of a control sample at 1 Hz frequency from 
a frequency sweep of frozen PG mucin and from a frequency sweep of PSIM. Lissajous data from the 
52 | P a g e  
 
other PG mucin samples are not given, but they show a similar degree of noise as the PG mucin control 
sample. The Lissajous data from the PSIM control sample follows an even elliptical curve. Also, the 
three iterations are similar, which suggest that the measurements are stable. The PG mucin control 
sample, on the other hand, show a high degree of noise. The data does not follow any defined curve, 
and the iterations are in disagreement. These are clear signs that the PG mucin sample is unstable and 
that the response is low. Please note that these two graphs cannot be directly compared data point to 
data point because they are collected from different frequency sweeps run with different parameters. 
The right graph (PSIM) is included only to serve as a reference to how Lissajous plot should look in 
rheologically stable samples. 
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Figure 23. Stress plotted against strain (Lissajous plot) at 1 Hz frequency for porcine gastric (PG) mucin control to the left and 
porcine small intestinal mucus (PSIM) control to the right. The Lissajous data for PG mucin were collected from a frequency 
sweep at 10 °C from low to high frequency with constant strain 1E-3 and 1E-2 Pa start stress, while the Lissajous data for PSIM 
were collected from a frequency sweep at 20 °C from low to high frequency with constant strain 1E-3 and 1E-2 Pa start stress. 
Cone dimension for PG mucin was C 40 1 ETC and C 40 4 ETC for PSIM. Three iterations per data point. 
 
Even though the mechanical response of PG mucin entails that the rheological effect of 
alginate is inconclusive, it should still be possible to investigate the mobility in treated PG mucin 
samples using multiple particle tracking. Particle tracking is a non-invasive technique (Selvaggi et al., 
2010), and the results should therefore be viable. Carboxylated polystyrene nanoparticles (200 nm) 
were mixed with isotonic saline (control), alginate G-block DPn 12, alginate G-block DPn 24, alginate G-
block DPn 33 and alginate LFR 5/60 solutions respectively. The resulting nanoparticle solutions were 
added to PG mucin at a concentration of nanoparticles of 0.0025 %. The final concentration of PG 
mucin was 40 mg/mL, and the final concentration of alginate was 4.7 mg/mL. Mobility was investigated 
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by taking images every 70 ms for 20.09 seconds. The mean-square displacement (MSD) and effective 
diffusivities (Deff) values were calculated based on a video microscopy series of every PG mucin-
nanoparticle sample. MUC5AC is a key constituent of tracheobronchial, cervical and gastric mucus 
(Gendler and Spicer, 1995), and is the main determinant of the mucus gel-like properties (Lieleg et al., 
2010). Since PG mucin consists of MUC5AC and is structurally related to human mucin (Turner et al., 
1999), it should be a reasonable substitute to mucus for investigating particle mobility. Particle 
mobility depends on the steric and interactive filtering abilities of mucus (Lieleg et al., 2010).  
Figure 24 shows MSD values for PG mucin control sample and PG mucin treated with the four 
different alginates plotted against time scale (τ). The figure also shows the MSD values of the 
carboxylated nanoparticles in water depicted in the bottom right graph. The graph is given as 
perspective on how mobility in a low viscosity liquid lacking latticework looks. The movement of 
particles in water is very uniform because water does not contain any restricting matrix and carries no 
charge, and the velocities are high because the viscosity of water is much lower than that of PG mucin. 
PG mucin control and PG mucin treated with G24 and LFR show a wide distribution of MSD trajectories. 
This indicates that particles in the solution move with different speed which is common behaviour for 
particles immersed in an inhomogeneous medium (Crater and Carrier, 2010). Heterogeneity in particle 
velocities arise from variations in pore sizes; particles will have increased mobility as they traverse 
through larger pores, and decreased mobility as they traverse through tighter pores (Dawson et al., 
2003). Research has shown that particles with sizes up to 500 nm can move through mucus (Lai et al., 
2009), but that with larger particle sizes the MSD trajectories becomes more uniform (Dawson et al., 
2003). This is because the larger particles do not have free passage to move through pores, and must 
therefore follow restricted pathways (where the pore sizes are largest) resulting in uniform movement 
of particles. As can be seen in Figure 24, both the G12 treated and the G33 treated PG mucin sample 
have narrower distributions of MSD trajectories. The fastest and the slowest populations seen in the 
control sample, are not recognizable in the G12 or the G33 treated sample. This suggests that G12 and 
G33 treatment, not only open the smaller pores, but also diminishes the larger pores within the mucin 
structure. Possibly, the alginate G-blocks could cause large PG mucin pores to collapse due to alginate-
mucin interactions, while increasing the smaller pore sizes by competitive inhibition of mucin-mucin 
interactions. A similar scenario has been seen in CF mucus with treatment of rhDNase (Dawson et al., 
2003), where the authors proposed pore collapse due to entanglements. In the G12 and G33 samples 
there still exists some larger pores indicated by a small population of particles with high velocity. It was 
expected that the various alginate molecules would all show a narrower distribution, because alginate 
is a muco-adhesive that interacts with mucin molecules (Taylor Nordgård and Draget, 2011), which 
potentially changes mucin structural orientation. Granted, there are a lot of inconsistencies in the bulk 
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rheological measurements, but under the assumption that the observed rheological effect portray 
some truth, all alginate samples weakened the gel. It is therefore odd that especially G24 treatment of 
PG mucin did not cause a narrower distribution, since G24 has a molecular weight between G12 and 
G33 that both showed more uniform movement of particles through the sample. One explanation 
could be that G12 and G33 molecules are better distributed in the sample, and the effect is therefore 
observed in general for the particle population. As for the G24 and the LFR treated PG mucin samples, 
the effect might be localized, which leads to subpopulations with large differences in velocities. 
Another important aspect of mobility to take into effect is the interactive part. At ambient PG 
mucin pH (~4.5) the nanoparticles should be able to interact by electrostatic interactions through 
negative charges from carboxyl croups, hydrogen bonding through protonated carboxyl groups (due 
to acidic pH) and hydrophobic interactions through hydrophobic polystyrene beads (depending on the 
density of the coating). This means that the impediment of movement through PG mucin is influenced 
by several different interaction mechanisms. Most likely, mucin and particles would interact though all 
three types of interactions mentioned. However, the addition of alginate potentially changes the 
interactions between mucin and nanoparticles. Alginate is thought to bind to mucin molecules through 
electrostatic interactions with positively charged amino acids (Taylor Nordgård and Draget, 2011). Such 
binding would hide these interaction sites from the nanoparticles, causing less restrictive movement. 
In addition, because alginates also interact through hydrogen bonds due to some degree of 
protonation, they could potentially also hide hydrogen-binding sites from the nanoparticles. 
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Figure 24. Mean-square displacement (MSD) values for MQ-water, porcine gastric (PG) mucin control and PG mucin treated 
with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 plotted against time 
scale (τ). Fluorescent carboxylated nanoparticles (200 nm) were tracked by multiple particle tracking at a concentration of 
0.0025 %. The particles were tracked for 20.09 s. Concentration of PG mucin was 40 mg/mL and concentration of alginate 4.7 
mg/mL. The number of particle trajectories in each case in approximately 100. 
56 | P a g e  
 
An interesting point to make is that the velocity of particles immersed in PG mucin seem to 
scale with time scale. This is in contrast to particle movement through water where the particles have 
straight trajectories, which is typical for pure liquid materials (Selvaggi et al., 2010). This suggests that 
the behaviour must be caused by the mucin molecules. Indeed, such behaviour is typical for 
viscoelastic materials (Selvaggi et al., 2010), and it has been hypothesized that it arise from particles 
being trapped in mucin cages. At higher time scales the particle escape from these cages is more 
noticeable and the MSD values subsequently increase (Dawson et al., 2003, Crater and Carrier, 2010). 
The caging is most likely due to both steric hindrance and mucin-particle interactions. 
The MSD values depicted in Figure 24 show some degree of noise, especially towards the later 
time scales. Some of it might be caused by the resolution of the confocal microscopy used to track the 
particles (i.e. signal-to-noise ratio), but it is mainly caused by inaccuracies in MSD values at long time 
scales (Saxton and Jacobson, 1997). The most obvious noise towards the ends of the MSD trajectories 
have been removed prior to being plotted, because it was crowding the graphs. 
When tracking particles using multiple particle tracking, it is possible that the tracked 
trajectories follow the movements of the medium they are suspended in (Suh et al., 2005). Two 
randomly chosen trajectories for G12 treated PG mucin are given in Figure 25 and show that this is not 
the case here. The trajectories follow a randomized path, independent of each other. The trajectories 
also look like the start of a beads-on-a-string type of trajectory which is typical for sub-diffusive 
particles. This behaviour often arise from interactions holding a particle in place before it breaks free 
and moves on (Suh et al., 2005), and in the case of PG mucin, it could also symbol the pores. This means 
that each “bead” is an illustration of a particle trapped physically or by interactions, while the string is 
the transition between pores or the particle breaking free from their interactive prison. This is the type 
of movement that creates the time scale dependent increase in MSD values mentioned earlier. Note 
that not all the trajectories in all the samples are similar to the ones portrayed in Figure 25, but it 
illustrates that the measured movement of particles do not arise from movement of the mucin matrix. 
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Figure 25. Particle movement in x- and y- direction for fluorescent carboxylated polystyrene nanoparticles (200 nm) in porcine 
gastric (PG) mucin treated with alginate G-block DPn 12. The concentration of nanoparticles was 0.0025 %, the concentration 
of PG mucin was 40 mg/mL and the concentration of alginate was 4.7 mg/mL. The particles were tracked using a CLSM Leica 
SP5 confocal microscope for 20.09 seconds. 
 
The exception to the aforementioned explanation of particle mobility is the LFR treated 
sample. LFR treated PG mucin show many MSD trajectories with very low mobility, which distinguishes 
the LFR treated sample from the other alginate treated samples. The LFR treated sample seems to 
have two subpopulations of particles (shown with different colours in Figure 24).  One is extremely 
immobile, with very low velocities, while the other population has similar trajectories to the G24 
treated PG mucin sample. When tracking particles in the LFR treated PG mucin sample, aggregates of 
particles were observed. Figure 26 shows an image of LFR treated PG mucin compared with an image 
of PG mucin control, where the aggregates of nanoparticles can be seen as large green spots in the 
image to the left. It is hard to say what might have caused the aggregation, but it definitely has 
something to do with alginate LFR 5/60. The alginate-nanoparticle solutions and the control-
nanoparticle solution were added to two different batches of mucin (one that had been frozen, and 
one unfrozen). In both cases, only the sample treated with LFR showed aggregates. SEC-MALLS 
characterization of the LFR sample showed that the sample contained some aggregates, however, the 
volume of aggregates was negligible. In any case, the aggregates could not consist entirely of LFR 
molecules, because the negatively charged alginate molecules would repel the carboxylated 
nanoparticles due to electrostatic repulsion. A more reasonable explanation would be that the 
aggregates consist mainly of mucin molecules because mucin can trap and immobilize the 
nanoparticles through electrostatic adhesiveness (and possibly hydrogen bonding and hydrophobic 
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interactions), and that these mucin aggregates were caused by the LFR molecules. Whether this is 
because of impurities in the LFR sample or simply due to LFR-mucin interactions is impossible to say.  
 
 
Figure 26. Image of PG mucin treated with alginate LFR 5/60 to the left, and PG mucin with physiological saline (control) to 
the right. The images show fluorescent carboxylated particles (200 nm) distributed in each respective sample tracked by a 
CLSM Leica SP5 confocal microscope. Particle concentration was 0.0025 %. Concentration of PG mucin was 40 mg/mL and 
concentration of alginate 4.7 mg/mL. The zoom of the microscope is the same in both cases, and they were tracked with the 
same parameters. 
 
The carboxylated polystyrene nanoparticles were only tracked in x- and y- direction (xyt acquisition 
mode). Naturally there would be particle movement in z- direction as well as in x- and y- direction. In 
order to have an idea on how the particles move in all directions, the percentage of tracked particles 
was plotted against time scale (τ) in Figure 27. The figure shows how many of the original number of 
tracked particles that are still visible at any given time scale. Particle movement in MQ-water is again 
given as a perspective on how quickly the particles move out of camera focus or out of tracking 
parameters. As before, because water does not react or physically impede the particles, the high 
velocities make them only traceable to τ = 5 seconds. In all the PG mucin samples, some particles are 
tracked over the entire time scale. This supports the fact that PG mucin is a porous network of cross-
linked mucin monomers, because the movement of these particles are restricted to stay in x- and y- 
direction. It also restricts the particles to move too long in x- and y- direction, which would cause the 
software program to identify them as two separate particles. Based on the longest MSD trajectories in 
Figure 24 it is apparent that the particles does not lack mobility (apart from one subpopulation of LFR 
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treated PG mucin), so they are either held in xy-plane through interactions with mucin (and possibly 
alginate) molecules, by steric hindrance, or simply because of statistics (only traceable particles will 
remain towards the end no matter the cause). 
All alginate treated samples appear to have a steeper initial drop in value from 100 % tracked particles 
than PG mucin control. This means that the movement within the alginate treated PG mucin is greater 
than the movement within PG mucin control in all directions. However, the value of tracked particles 
for the LFR treated sample levels out after the initial drop, which refers to the immobile subpopulation 
in the LFR treated PG mucin sample. G12 and G33 treated PG mucin display similar trends in Figure 27. 
The amount of tracked particles steadily decrease over time scale. This is in agreement with the results 
depicted in Figure 24 that suggested more uniform movement of the carboxylated particles compared 
to the control sample. PG mucin treated with G24 seems to have the steepest downward slope, and 
displays higher movement than any other mucin sample. This is somewhat surprising, because G24 
treated PG mucin seems to have a large part of its matrix intact according to Figure 24. As mentioned 
earlier, a localized effect of G24 could explain these results. 
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Figure 27. Percentage of tracked particles in porcine gastric (PG) mucin control and PG mucin treated with alginate G-block 
DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 plotted against time scale (τ). The values are 
based on the MSD values in Figure 24. Fluorescent carboxylated nanoparticles (200 nm) were tracked by multiple particle 
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tracking at a concentration of 0.0025 %. The particles were tracked for 20.09 s. Concentration of PG mucin was 40 mg/mL 
and concentration of alginate 4.7 mg/mL. 
 
Investigating effective diffusivities (Deff) is a good way of determining whether particle 
movement is active, diffusive or sub-diffusive (Suh et al., 2005). Ensemble effective diffusivity (<Deff>) 
values for PG mucin control and PG mucin treated with G12, G24, G33 and LFR is plotted against time 
scale (τ) in Figure 28. The vertical lines in the graph corresponds to 80 % of the tracked particles 
remaining in camera focus or within tracking parameters. The figure shows that the carboxylated 
polystyrene nanoparticles in all samples are sub-diffusive, and that the mobility is greatest for LFR and 
G24 treated PG mucin at short time scales. However, when 80 % of the tracked particles have 
disappeared out of camera focus or out of tracking parameter, the two samples become less mobile. 
The LFR treated PG mucin sample has immobile subpopulations as mentioned before, which is why the 
ensemble effective diffusivities drops quickly. At longer time scales the G12 and G33 treated PG mucin 
samples show highest particle mobility. This supports the MSD data suggesting a more uniform 
movement through G12 and G33 treated PG mucin. The even <Deff> slopes indicate that the samples 
does not contain any marked subpopulations. 
Interestingly, the diffusivity through PG mucin control sample is very similar to the diffusivity 
through G12 and G33 treated PG mucin, at least up until 7 seconds. This is probably because the sample 
displayed a wide distribution of MSD trajectories (Figure 24), with many particles exhibiting high 
velocities. The reason that PG mucin control has a population of particles with high speed could be the 
amount of ions in the solution. The control sample consist of isotonic saline, and even though the ionic 
strength is equal between the control and the alginate treated samples, there still exists more ions in 
the control solution compared to the alginate solution. This is because alginate are multivalent ions, 
which contribute more to the ionic strength than monovalent ones (Smidsrød et al., 2008). Because 
saline consists only of monovalent ions, more ions need to be added to match the ionic strength of the 
alginate solution. The positively charged monovalent ions are thought to be able to shield the 
negatively charged surface of the carboxylated polystyrene nanoparticles, which decreases the 
electrostatic interactions between the nanoparticles and the mucin molecules (Lieleg et al., 2010). 
Such decrease in interactions between mucin molecules and nanoparticles means the particles are 
shielded from interactive impediment, and the particles will only be hindered physically. This might 
cause a general increase in particle mobility (Lieleg et al., 2010).  
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Figure 28. Ensemble effective diffusivities (<Deff>) of porcine gastric (PG) mucin control and PG mucin treated with alginate 
G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 plotted against time scale (τ). The 
trajectories are based on the MSD values in Figure 24. Fluorescent carboxylated nanoparticles (200 nm) were tracked by 
multiple particle tracking at a concentration of 0.0025 %. The particles were tracked for 20.09 s. Concentration of PG mucin 
was 40 mg/mL and concentration of alginate 4.7 mg/mL. 
 
 
3.4 The effect of alginate on native porcine tracheobronchial mucus 
 
The continuance of the results in this thesis is aimed at human tracheobronchial mucus. It is 
therefore interesting to investigate the effect of alginate on porcine tracheobronchial mucus (PTBM) 
directly, because the results should be more comparable than the effect of alginate on bio-similar 
mucus, PSIM or PG mucin due to more similarities in gene products and general molecular 
composition. The trachea of newly slaughtered pig were opened, and the mucus scraped using a metal 
spoon. The mucus was collected in Eppendorf tubes and stored at -20 °C. Only the effect of alginate G-
block DPn 12 was investigated due to small amounts of PTBM available. Most of the mucus collected 
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was tainted with blood, which could have unfortunate impact on PTBM rheology. G12 was mixed with 
the PTBM at a concentration of 3.4 mg/mL. Preferably, the concentration of alginate should have 
mimicked that of the other mucus/mucin systems, but the quantity of PTBM did not allow for that. In 
addition, the G12 treated sample was rheologically tested at different values of stress and strain than 
the other systems, but assuming all values were measured within each respective samples linear 
viscoelastic area, they can still be compared. 
Elastic modulus and phase angle values of the G12 treated PTBM and PTBM untreated are 
compared and plotted against frequency in Figure 29. There was unfortunately not enough sample to 
make a control with isotonic saline for the treated PTBM, and some of the dissimilarities between the 
samples in Figure 29 might arise from differences in ionic strength. It is also probable that some of the 
differences arise from the dilution that has happened with the addition of alginate G-block DPn 12. 
Studies have shown that an increase in ionic strength can lead to a significant lowering of PG mucin 
viscosity (gel weakening) (Bhaskar et al., 1991). However, based on literature (Taylor Nordgård and 
Draget, 2011, Draget and Taylor, 2011, Taylor et al., 2007, Draget, 2011) and the observed effect of 
G12 on PSIM, the effect of G12 on PTBM seems legitimate. It is therefore safe to conclude that alginate 
G-block DPn 12 weakens mucus gel. The effect of G12 on PTBM seems to be larger than on PSIM even 
after taking some differences due to dilution and ionic strength into account. The elastic modulus 
values of the PSIM samples were very varying, and drawing any conclusions from G’ values cannot be 
supported. The phase angle values, however, are more comparable, because they have been shown 
to be more stable throughout this thesis and literature (Sanders et al., 2000). One reason for the 
increased effect of G12 on PTBM compared to PSIM could be because of different alginate 
concentration. Alginate G-block DPn 12 was added to PTBM at a lower concentration than to PSIM. 
However, had the observed differences been because of concentration, it would have been expected 
that alginate had a bigger weakening effect on PSIM instead of PTBM. A more sound explanation would 
relate to differences in mucus composition and mucin gene products. PSIM and PTBM both contain 
many different inherent substances. The quantity of these compounds would naturally differ from the 
two samples because the mucus have different responsibilities regarding particulate transport and 
protective capabilities. PSIM is more used to harsher environments in general, and could have an 
increased tolerance towards potential threats. Purely based on the results gathered here, it is not 
possible to pinpoint why the effect of G12 is more pronounced on PTBM than on PSIM.  
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Figure 29. Elastic modulus (G’) and phase angle (δ) values for untreated porcine tracheobronchial mucus (PTBM) and PTBM 
treated with alginate G-block DPn 12 compared. Concentration of alginate was 3.4 mg/mL. Values are from frequency sweeps 
at 20 °C from low to high frequency at constant strain 5E-2 and 1 Pa start stress. Cone dimension was C 25 1 ETC. 
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4 Conclusion 
 
The effect of alginate G-blocks and LFR 5/60 have been investigated on bio-similar mucus, PSIM, PTBM 
and PG mucin throughout this thesis. The bio-similar mucus reacted very differently to the presence 
of alginate compared to PSIM, even though it is meant to represent a model system of PIM. This is 
because of the structural differences. The bio-similar mucus gel is stabilized by both polyacrylic acid 
and commercialized mucin, which means that both polymers have potential to interact with the 
alginate molecules. It is therefore likely that polyacrylate-alginate electrostatic repulsion led to phase 
separation, causing the G-block DPn 33 and LFR 5/60 treated bio-similar mucus samples to have weaker 
gel profiles than G-block DPn 12 treated bio-similar mucus and control. The bio-similar mucus is 
therefore not viable as a model system for PIM behaviour under influence of other muco-adhesive 
molecules – at least other negatively charged polymers. 
Both lot#1 and lot#2 of PG mucin suffered from instabilities. PG mucin rheology was heavily 
influenced by pH, temperature, hydration time and low mechanical response. The rheological effect of 
alginate on PG mucin is therefore inconclusive and the experiments should be redone with a more 
mechanically stable PG mucin sample. Based on PSIM and PTBM, alginate G-block DPn 12 has a 
weakening effect on mucus gel structure. Alginate G-block DPn 33 and LFR 5/60 have a minor 
strengthening effect on PSIM. The difference between PSIM control and PSIM treated with G-block 
DPn 33 was minimal, and there may therefore exist alginate molecules with molecular weights close to 
that of G-block DPn 33 that does not influence mucus rheology. G33 treated PG mucin, in addition to 
G12 treated PG mucin, had highest mobility at long time scales. The MSD trajectories were also 
narrower, which is indicative of uniform pore sizes. The effect is possibly a consequence of alginate-
mucin interactions through electrostatic forces and hydrogen bonding causing the smaller pores to 
open up, while collapsing some of the larger pores. G24 and LFR treated PG mucin showed a wide 
distribution of MSD trajectories indicative of large subpopulations. This also became apparent by 
expressing the highest particle mobility at short time scales, and lowest mobility at long time scales. 
Aggregates were observed in the LFR treated PG mucin sample, most definitely caused by the addition 
of LFR, but the underlying reason is unknown.  
The rheological effect of alginate G-block DPn 33 on PSIM and the effect on PG mucin particle 
mobility supports the hypothesis that there exists a specific molecular weight alginate molecule that 
increases particle mobility without influencing mucus rheology, but further experiments should be 
performed to verify this.  
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5 Future work 
 
Molecular weight alginate G-blocks with chain lengths close to DPn 33 could according to the results 
obtained in this thesis have potential to influence particle mobility without affecting mucus rheology. 
However, more work is needed to ascertain that this is true for native tracheobronchial mucus. The 
rheological impact of alginate G-block DPn 33 has only been investigated on porcine small intestinal 
mucus here, which contains different gene products and molecular composition compared to 
tracheobronchial mucus. Porcine gastric mucin is a viable substitute, and the rheological effect of 
alginate on porcine gastric mucin should therefore be investigated further, with a sample that is 
mechanically stable. In addition, particle mobility should be studied in native mucus samples since they 
are more complex than porcine gastric mucin. The ideal scenario would be to investigate the effect of 
alginate on both particle mobility and rheology on native tracheobronchial mucus. For this purpose it 
might be a good idea to measure the microrheology, instead of the bulk rheology as is done in this 
thesis, because tracheobronchial mucus is hard to acquire in large quantities. In addition, particle 
tracking should be performed with particles with different sizes and surface characteristics to get a 
more dynamic view of what happens to the structure and function after addition of alginate. Future 
work should also include diffusion and permeability studies on mucus treated with alginate, and not 
just particle mobility. 
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Appendix A: Bio-similar mucus protocol 
 
The bio-similar mucus consist of a lipid part and a polymer part. This protocol makes 10 mL bio-similar 
mucus. 
Preparation: 
1. Make 10 mM isotonic HEPES buffer containing 1.3 mM CaCl2, 1 mM MgSO4 and 137 mM NaCl. 
HEPES.  
2. Make 10 mM non-isotonic HEPES buffer containing 1.3 mM CaCl2 and 1 mM MgSO4. 
Lipid solution: 
3. Mix 0.0121 g linoleic acid with 0.0396 g cholesterol and 0.033 g phosphatidylcholine in an 
Eppendorf tube.  
4. Add 0.03586 g polysorbate tween 80 and two small magnets.  
5. Add 750 µL isotonic 10 mM HEPES buffer and leave the mixture on vigorous magnetic stirring 
while preparing the polymer solution. The lipid solution must be homogenous before being 
added to the polymer solution. 
Polymer solution: 
6. Mix 0.09 g polyacrylic acid with non-isotonic 10 mM HEPES buffer, and leave on vigorous 
magnetic stirring until dissolved.  
7. Add 0.5 g Sigma mucin type II and mix until dissolved.  
8. Add 150 µL 5 mM NaOH and make sure the solution is homogenous before proceeding. 
Completion: 
9. Add 0.682 mL of the lipid solution into the polymer solution. Stir. 
10. Add 0.31 g bovine albumin and stir until dissolved.  
11. Adjust pH to 7.4 with NaOH. 
12. Store the solution cold overnight at ~3 °C before further utilization. 
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Appendix B: Porcine gastric mucin purification protocol 
 
Porcine gastric mucus gels were removed from the mucosa and immediately transferred into an ice 
cold cocktail of protease inhibitors (Table B.1) in phosphate buffer (mucus to buffer ratio 1:4 v/v), pH 
6.5, to prevent degradation by endogenous proteases.  Mucus gel was solubilised in the inhibitor 
cocktail by high speed homogenisation in a Waring Blender for 1 minute.  Soluble material was 
separated from insoluble cell debris by centrifugation (8000g, 1 hour, 4oC).  The resulting supernatant 
was further purified to remove protein and nucleic acid by equilibrium density gradient 
ultracentrifugation in caesium chloride (CsCl) (Starkey et al., 1974).  CsCl was added to give a starting 
density of 1.42 g/ml, and the solution centrifuged at 100,000g for 48 h at 4oC, using a fixed angle rotor. 
The contents of each tube were removed as nine equal fractions with care being taken not to 
disturb the density gradient.  The density of each fraction was measured, followed by exhaustive 
dialysis against distilled water at 4oC.  Dialysed fractions were assayed for glycoprotein, protein and 
nucleic acid.  Fractions rich in protein and nucleic acid were discarded, and those rich in glycoprotein 
were pooled, freeze dried and stored at –20oC. 
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Table B-1. Concentration and action of protease inhibitors within the proteolytic inhibitor cocktail. 
Protease inhibitor Concentration 
(mM) 
Mode of action  
 
Phenylmethylsulphonyl 
fluoride 
 
3 Inhibitor of serine proteases, e.g., elastase 
hydrolyses peptide bond at C-terminal side, and 
cathepsin and trypsin removes N-terminal 
dipeptides. 
Sodium iodoacetate 1 Inhibitor of thiol-dependent proteases, e.g., 
cathepsin B and other disulphide dependent 
enzymes. 
Benzamidine 
Hydrochloride 
15 Specific inhibitor of trypsin and trypsin-like 
serine proteases (hydrolysis of proteins, 
peptides and amino acids). 
Na2 EDTA 10 Inhibitor of metallo-dependent proteases, e.g., 
Ca2+ dependent enzymes. 
N-ethylmaleimide 10 Prevents disulphide group exchange. 
ε-amino caproic acid 100 Inhibitor of plasminogen activation to serine 
protease plasmin (hydrolyses peptide and ester 
bonds). 
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Appendix C: SEC-MALLS of alginate LFR 5/60 
 
Below is given the SEC-MALLS chromatogram for alginate LFR 5/60 in Figure C-1 and Fable C-1 shows 
the analysis of the data using exponential fit. 
 
Figure C-1. SEC-MALLS spectra of an alginate LFR 5/60 sample showing both the refractive index (RI) signal which shows the 
eluted mass of the sample, and the light scattering (LS) signal which shows the molecular sizes. Molar mass (g/mol) is plotted 
against volume (mL). There were three injections (blue, red and teal colour), with two different volumes. 
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Table C-1. Data analysis of SEC-MALLS experiment on alginate LFR 5/60 using exponential fit to data. Mn = number-average 
molecular weight. Mw = weigh-average molecular weight.  
Sample Mn (kDa) Mw (kDa) Polydispersity Injected mass (µg) Mass recovery (%) 
# 1 (red) 11.700 ± 
0.008 
32.800 ± 
0.003 
2.794 ± 0.008 500.000 69.400 
# 2 (blue) 12.700 ± 
0.006 
32.900 ± 
0.002 
2.581 ± 0.007 750.000 69.500 
# 3 (teal) 12.700 ± 
0.006 
32.000 ± 
0.002 
2.530 ± 0.006 500.000 70.000 
Average 12.400 32.600 2.635 583.333 69.600 
Standard 
deviation 
0.800 0.700 0.155 144.340 0.300 
Standard 
deviation (%) 
6.300 2.100 5.893 24.740 0.500 
Minimum 11.700 32.000 2.530 500.000 69.400 
Maximum 12.700 32.900 2.794 750.000 70.000 
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Appendix D: NMR of alginate G-blocks 
 
The 1H NMR spectra from a BRUKER Avance DPX 300 equipped with a 5 mm QNP probe for alginate G-
block DPn 12, G-block DPn 24 and G-block DPn 33 are given Figure D-1, D-2 and D-3 respectively.  
 
Figure D-1. 1H NMR spectrum of alginate G-block DPn 12 using a 300 MHz NMR instrument.  
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Figure D-2. 1H NMR spectrum of alginate G-block DPn 24 using a 300 MHz NMR instrument. 
 
Figure D-3. 1H NMR spectrum of alginate G-block DPn 33 using a 300 MHz NMR instrument. 
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All calculations are based on sequential parameter A-C and the different reducing ends, all 
shown in figure D-4 in the spectrum for the alginate G-block DPn 12 sample. The method is explained 
by Grasdalen (Grasdalen, 1983) for G-heavy alginates, who described signal assignments used for 
determining the sequential parameters shown in the figure. 
 
 
Figure D-4. 1H NMR spectrum of alginate G-block DPn 12 on a 300 MHz NMR instrument showing the NMR signals used as 
basis for the sequential parameters A-C. It also shows the location of the reducing ends of the polysaccharide and their 
orientation. 
 A method called “maximum averaging” (Kristiansen) was used to determine the fraction of M 
and G in the alginate samples. This method uses intermediate values based on the sequential 
parameters A-C (Figure D-4) that can be calculated according to equation D.1-D.8. 
𝐼(𝐺) = 0.5 ∗ ((𝐴 + 𝐶) + 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3))     (D.1) 
𝐼(𝑀) = 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3) + 𝐵4       (D.2) 
𝐼(𝐺𝐺) = 0.5 ∗ ((𝐴 + 𝐶) − 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3))     (D.3) 
𝐼(𝐺𝑀) = 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3)       (D.4) 
𝐼(𝑀𝑀) = 𝐵4          (D.5) 
𝐼(𝐺𝐺𝑀) = 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3) ∗
𝐵1
𝐵1+𝐵2
      (D.6) 
𝐼(𝑀𝐺𝑀) = 0.5 ∗ (𝐵1 + 𝐵2 + 𝐵3) ∗
𝐵2
𝐵1+𝐵2
      (D.7) 
𝐼(𝐺𝐺𝐺) = 𝐺𝐺 − 𝐺𝐺𝑀         (D.8) 
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Because the alginate oligosaccharides are short chains, it is necessary to consider the reducing 
ends when doing the calculations because the reducing end signals compared to the others signals are 
higher than they would have been for larger alginate molecules. There are several ways to use the 
reducing ends, all involving both an alpha oriented and a beta oriented reducing end. The G5 β 
reducing end is hidden beneath another signal (Figure D-4) and is therefore not used in the 
calculations. This should theoretically leave two possible ways of doing calculations with the reducing 
ends –G1 red β + G5 red α and G1 red β + G1 red α. However, the signal for G1 red β has a neighbouring 
signal (Figure D-4) that is difficult to assess whether or not it is a part of the reducing end signal. 
Therefore a third possibility for using the reducing ends in the calculations arises, which is using G1 red 
β↑ + G1 red α. The intermediate values originating from equations D.1-D.8 can be used to calculate 
fractions of G and M according to equation D.9-D.17. The equation for calculating ?̅?𝐺>1 and DPn is 
given in equation D.18 and D.19 respectively. F(G)total is the sum of F(G)internal and F(G)red.ends. 
𝐹(𝐺)𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 =
𝐼(𝐺)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.9) 
𝐹(𝐺)𝑟𝑒𝑑.𝑒𝑛𝑑𝑠 =
𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.10) 
𝐹(𝑀) =
𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
        (D.11) 
𝐹(𝐺𝐺)𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 =
𝐼(𝐺𝐺)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.12) 
𝐹(𝐺𝑀) = 𝐹(𝑀𝐺) =
𝐼(𝐺𝑀)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.13) 
𝐹(𝑀𝑀)𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 =
𝐼(𝑀𝑀)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.14) 
𝐹(𝐺𝐺𝐺)𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 =
𝐼(𝐺𝐺𝐺)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
       (D.15) 
𝐹(𝐺𝐺𝑀) = 𝐹(𝑀𝐺𝐺) =
𝐼(𝐺𝐺𝑀)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
      (D.16) 
𝐹(𝑀𝐺𝑀) =
𝐼(𝑀𝐺𝑀)
𝐼(𝑀)+𝐼(𝐺)+𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
        (D.17) 
?̅?𝐺>1 =
𝐹(𝐺)−𝐹(𝑀𝐺𝑀)
𝐹(𝐺𝐺𝑀)
         (D.18) 
𝐷𝑃̅̅ ̅̅ 𝑛 =
𝐹(𝐺)𝑡𝑜𝑡𝑎𝑙+𝐹(𝑀)
𝑟𝑒𝑑.𝑒𝑛𝑑𝑠
         (D.19) 
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Appendix E: HPAEC-PAD for alginate G-blocks 
The HPAEC-PAD spectra for alginate G-block DPn 12, 24 and 33 is given in Figure E-1, E-2 and E-3 
respectively. 
 
Figure E-1. HPAEC-PAD spectrum of alginate G-block DPn 12. 
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Figure E-2. HPAEC-PAD spectrum of alginate G-block DPn 24. 
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Figure E-3. HPAEC-PAD spectrum of alginate G-block DPn 33. 
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 In order to quantify of each sample, a molar response factor is required. This factor can be 
calculated according to equation E.1: 
𝑅𝑓𝑥 = (
𝐴𝑥
𝑚𝑥
)       (E.1) 
where Rfx is the response factor, Ax is the area of the chromatographic peak and mx is the concentration 
of the oligomer. Plotting the molar response factor against DP gives a curve that can be used to 
calculate molar concentration (Cx), number average (Xn), weight average (Wn) and molecular 
distribution (DPn) within the sample through linear regression. For this experiment, the linear 
regression of the molar response factor is given in equation E.2. 
𝑅𝑓 = 1.0037 ∗ ln(𝐷𝑃) + 0.1682       (E2) 
Equation E.2 was used to calculate DPn for all three alginate samples, but example of calculation is only 
given for the alginate G-block DPn 12 sample in Table E-1.  
 
Table E-1. Calculated values of molar concentration (Cx), number average (Xn), weight average (Wn) and molecular distribution 
(DPn) for alginate DPn 12 based on the chromatogram in figure F-1. The equations used to calculate the values are given in the 
bottom of the table. 
DP Peak# mx Cx Wn Xn DPn 
2 1 0.415 146.113 0.001 0.004 0.008 
3 2 0.906 478.509 0.002 0.009 0.027 
4 3 3.525 2482.661 0.012 0.035 0.142 
5 4 6.255 5507.245 0.026 0.063 0.314 
6 5 7.972 8423.190 0.040 0.080 0.481 
7 6 7.896 9733.420 0.046 0.079 0.556 
8 7 7.375 10389.901 0.049 0.074 0.593 
9 8 7.917 12547.166 0.059 0.080 0.716 
10 9 7.012 12348.996 0.059 0.071 0.705 
11 10 6.864 13295.820 0.063 0.069 0.759 
12 11 6.582 13909.746 0.066 0.066 0.794 
13 12 5.533 12667.427 0.060 0.056 0.723 
14 13 4.376 10789.739 0.051 0.044 0.616 
15 14 4.224 11158.790 0.053 0.042 0.637 
16 15 3.612 10177.474 0.048 0.036 0.581 
17 16 2.995 8965.705 0.042 0.030 0.512 
18 17 2.468 7822.913 0.037 0.025 0.447 
19 18 1.584 5299.609 0.025 0.016 0.303 
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20 19 1.831 6447.390 0.031 0.018 0.368 
21 20 1.508 5575.160 0.026 0.015 0.318 
22 21 1.277 4948.588 0.023 0.013 0.283 
23 22 1.020 4132.526 0.020 0.010 0.236 
24 23 0.854 3609.040 0.017 0.009 0.206 
25 24 0.769 3387.051 0.016 0.008 0.193 
26 25 0.622 2849.814 0.014 0.006 0.163 
27 26 0.550 2615.321 0.012 0.006 0.149 
28 27 0.475 2342.623 0.011 0.005 0.134 
29 28 0.380 1939.438 0.009 0.004 0.111 
30 29 0.362 1913.807 0.009 0.004 0.109 
31 30 0.304 1656.958 0.008 0.003 0.095 
32 31 0.266 1500.141 0.007 0.003 0.086 
33 32 0.226 1311.224 0.006 0.002 0.075 
34 33 0.195 1170.315 0.006 0.002 0.067 
35 34 0.165 1015.071 0.005 0.002 0.058 
36 35 0.148 936.717 0.004 0.001 0.053 
37 36 0.129 840.990 0.004 0.001 0.048 
38 37 0.112 752.713 0.004 0.001 0.043 
39 38 0.089 614.577 0.003 0.001 0.035 
40 39 0.079 559.046 0.003 0.001 0.032 
41 40 0.082 589.023 0.003 0.001 0.034 
42 41 0.067 494.187 0.002 0.001 0.028 
43 42 0.060 452.420 0.002 0.001 0.026 
44 43 0.056 431.336 0.002 0.001 0.025 
45 44 0.048 384.013 0.002 0.000 0.022 
46 45 0.040 323.337 0.002 0.000 0.018 
47 46 0.034 285.291 0.001 0.000 0.016 
48 47 0.032 274.411 0.001 0.000 0.016 
49 48 0.025 211.571 0.001 0.000 0.012 
50 49 0.021 188.585 0.001 0.000 0.011 
51 50 0.020 180.077 0.001 0.000 0.010 
52 51 0.018 160.370 0.001 0.000 0.009 
53 52 0.014 134.162 0.001 0.000 0.008 
54 53 0.013 127.417 0.001 0.000 0.007 
55 54 0.011 107.941 0.001 0.000 0.006 
56 55 0.008 81.546 0.000 0.000 0.005 
57 56 0.040 399.968 0.002 0.000 0.023 
Total:  99.463 211088.587 1.000 1.000 12.052 
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Equation:  𝑚𝑥 = 𝐴𝑥/𝑅𝑓𝑥 𝐶𝑥
= 𝑚𝑥 ∗ 𝑀0
∗ 𝑃𝑒𝑎𝑘# 
𝑊𝑛
= 𝐶𝑖/𝐶𝑡𝑜𝑡𝑎𝑙 
𝑋𝑛
= 𝑚𝑖/𝑚𝑡𝑜𝑡𝑎𝑙 
𝐷𝑃𝒏
= 𝐷𝑃𝑖 ∗ 𝑋𝑖 
 
 
 There are some differences between the results gathered from NMR and HPAEC-PAD. 
Regarding the shortest alginate G-block sample, the two methods are in full agreement. The medium 
length G-block sample also show good similarity. However, regarding the longest chained alginate G-
block, the two methods do not agree. For this sample, the NMR result was chosen, because the HPAEC-
PAD method suffer from poor resolution when the alginate chain lengths become too long. With chains 
over DP 30-35 (Ballance et al., 2005), base line separation is not good enough, as is seen in Figure E-3. 
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Appendix F: Confocal laser scanning microscope setup 
 
The parameters used to track Fluospheres ® Carboxylate-modified microspheres (0.2 µm, yellow-green 
fluorescent (505/515), 2 % solids. Invitrogen, Oregon, USA. Lot#714135) with CLSM Leica SP5 from 
Leica microsystems (Mannheim, Germany) is given in table F-1. 
 
Table F-1. Parameters used to track Fluospheres ® Carboxylate-modified microspheres (0.2 µm, yellow-green fluorescent 
(505/515), 2 % solids. Invitrogen, Oregon, USA. Lot#714135) with CLSM Leica SP5 from Leica microsystems (Mannheim, 
Germany). The particle concentration was 0.0025 % in porcine gastric (PG) mucin sample with concentration of 40 mg/mL. 
Parameter Value 
Laser Argon 
Laser power 20 % 
Detector PMT3 
Detector spectra Emission 514 nm 
Excitation 520 – 550 nm 
Detector power 5 % 
Smart gain 750.2 V 
Smart offset - 1 % 
Resolution 512 x 512 pixels 
Scan speed 8000 Hz 
Image size 65.08 x 65.08 µm 
Pixel size 127.35 x 127.35 nm 
Acquisition mode xyt 
Time interval Minimize 
Time duration 20.09 s (287 frames) 
Objective HCX PL APO CS 63 x 1.2 water 
Zoom 3.78 
Pinhole 111.44 (Airy 1) 
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Appendix G: ImageJ video microscopy analysis 
 
The images captured with CLSM Leica SP5 were loaded into ImageJ as “.lif” files. The particle tracker 
2D/3D option under the mosaic plugin was used to locate the fluorescent particles immersed in the 
mucus. The parameters used is given in Table G-1. 
 
Table G-1. Parameters used to process “.lif” images captured with CLSM Leica SP5 in order to calculate MSD values. 
Parameters Value 
Radius 3 pixels 
Cut-off 0 pixels 
Percentile 0.1 % 
Link range 20 frames 
Displacement 10 pixels 
 
The radius equals to the approximate particle size in pixels (Levy). The particles were 200 nm 
in size, so a radius of 3 was used because the microscope resolution makes the particles seem a bit 
larger than they really are. The particles were measured to appear as approximately 300 nm in size 
through the microscope. There was an even distribution of particles in most of the samples and the 
cut-off was consequently set to 0 pixels. The cut-off value is more valuable if the samples were 
crowded with fluorescent nanoparticles. The percentile value determines the amount of particles 
based on the particle excited light intensity. The displacement value is the maximum number of pixels 
a particle can traverse between frames in order to be ascertained as the same particle, while the linking 
range is the number of subsequent frames a particle must be tracked in order to appear in the analysis 
screen. 
After deciding the parameters, the trajectories for all tracked particles can be visualized and 
the x- and y- coordinates retrieved. The x- and y- coordinates for each particle is run through a Matlab 
program to achieve MSD values for each particle (Appendix H).  
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Appendix H: Matlab program for MSD determination 
 
The Matlab code was created by Astrid Bjørkøy in 2011 in order to translate x- and y- coordinates from 
ImageJ processing on particles tracked with CLSM Leica SP5 into mean-square displacement (MSD) 
values. The resulting MSD trajectories were saved as a “.txt” file. The Matlab code is given below. 
%function ParticleTracker 
% Prompt for lag time between frames 
% Promt for name of resultfile! 
prompt = {'Enter time interval:','Enter name of result file:'}; 
dlg_title = 'Input for Trajectory Calculations'; 
num_lines = 1; 
def = {'1','results.txt'}; 
answer = inputdlg(prompt,dlg_title,num_lines,def); 
timeinterval = str2double(answer{1}); 
filnavn = answer{2}; 
% Open the file with the trajectory data 
[File, Path] = uigetfile('*.txt','Open Trajectory file',... 
          'M:\Mikroskopi\Catherine Taylor\','MultiSelect','Off') 
s1 = char(strcat(Path,File)); 
fid = fopen(s1); 
DELIMITER = ' '; 
HEADERLINES = 1; 
k = 1; 
% Figure out what trajectories are in this file, put the names in 
% Nr.Trajectory and the number of frames for particle k in Particles 
while 1 
    tline = fgetl(fid); 
    if ~ischar(tline),   break,   end 
    if ~isempty(tline) 
        if tline(1) == '%' 
            nr = 0; 
            Nr(k).Trajectory = tline(4:end); 
            k = k+1; 
        else nr = nr+1; 
        end 
    else Particles(k-1) = nr;  
    end 
end 
fclose(fid); 
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% Import the trajectory data and put data in newData1 
newData1 = importdata(s1, DELIMITER, HEADERLINES); 
% Create new variables in the base workspace from those fields. 
vars = fieldnames(newData1); 
for i = 1:length(vars) 
    assignin('base', vars{i}, newData1.(vars{i})); 
end 
j = 1; 
pend = 0; 
% For each particle, calculate the msd's for each time step! 
% The frame number and (x,y) for each particle are between pstart and pend 
% in the data file newData1. 
for particle = 1:length(Particles) 
    Nr(particle).Trajectory 
    pstart = pend + 1; 
    pend = pstart + (Particles(particle)-1); 
    % p is an array containing the frame numbers 
    p = newData1.data(pstart:pend,1); 
    x = newData1.data(pstart:pend,2); 
    y = newData1.data(pstart:pend,3); 
    % maxstep is the maximum lag time possible for the particle 
    maxstep = p(end)-p(1); 
    for step = 1:maxstep 
        ave = [];  % vector of msd's 
        i = p(1);  % number of startframe 
        while i+step <= p(end) 
            % ignore frames missing! 
            if ~ismember(i,p) || ~ismember((i+step),p) 
            else 
                % find the correct position in p, x and y for i and i+step 
                i1 = find(p==i);  
                i2 = find(p==(i+step)); 
                new =((x(i1)-x(i2))^2 + (y(i1)-y(i2))^2); 
                ave = [new ave]; 
            end 
            i = i+1; 
        end 
        if ~isempty(ave) 
            msd(particle, step) = mean(ave); %mean msd for this step/lag time 
        end 
    end 
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end 
% Save the data to a file: lag time in first column, data for the 
% particles in the other columns. 
 datafile = strcat(Path, filnavn); 
 fid = fopen(char(datafile),'a'); 
 fprintf(fid,'%s', 'Step'); 
 for i = 1:length(Particles) 
     fprintf(fid,'\t %s',Nr(i).Trajectory); 
 end 
 fprintf(fid,'\n') 
 % size(msd,2) is the maximum number of frames for the particles 
 % in the data file newData1 
 for i = 1:size(msd,2) 
     fprintf(fid,'%6.4f \t', i*timeinterval); 
     for j = 1:length(Particles) 
         % if there's data missing for this lag time, skip info! 
         % else save the result 
         if msd(j,i) == 0 fprintf(fid,'\t'); 
         else fprintf(fid,'%6.4f \t',msd(j,i)); 
         end 
     end 
     fprintf(fid,'\n'); 
 end 
 fclose(fid); 
 clear all 
%end 
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Appendix I: Bio-similar mucus treated with alginate G-block DPn 12 
replicates 
 
Replicates of alginate G-block DPn 12 treated bio-similar mucus is given in Figure I-1 and I-2. 
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Figure I-1. Elastic modulus (G’) and phase angle (δ) values for bio-similar mucus control (saline) and bio-similar mucus treated 
with alginate G-block DPn 12 compared. Concentration of alginate was 4.7 mg/mL. Values are from frequency sweeps at 20 
°C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of bio-similar mucus 
control was a constant strain of 1E-3 and 2E-2 Pa start stress, while the parameters of the treated bio-similar mucus was a 
constant strain of 9E-4 and 2E-2 Pa start stress. 
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Figure I-2. Elastic modulus (G’) and phase angle (δ) values for bio-similar mucus control (saline) and bio-similar mucus treated 
with alginate G-block DPn 12 compared. Concentration of alginate was 4.7 mg/mL. Values are from frequency sweeps at 20 
°C from low to high frequency with cone dimension C 40 4 ETC. The parameters of the frequency sweep of bio-similar mucus 
control was a constant strain of 1E-3 and 2E-2 Pa start stress, while the parameters of the treated bio-similar mucus was a 
constant strain of 6E-4 and 1E-2 Pa start stress.  
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Appendix J: Frequency sweeps of frozen PG mucin lot#2 samples at 5E-
3 and 1E-2 strain 
 
The frequency sweeps of frozen PG mucin lot#2 treated with alginate G-block DPn 12, DPn 24, DPn 33, 
alginate LFR 5/60 and saline (control) at 5E-3 and 1E-2 strain is given in Figure J-1 and J-2 respectively. 
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Figure J-1. Elastic modulus (G’, left graph) and phase angle (δ, right graph) values for porcine gastric (PG) mucin control (saline) 
and PG mucin treated with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 
compared. All values are from frequency sweeps at 10 °C from low to high frequency with constant strain 5E-3 and 1E-2 Pa 
start stress. Cone dimension was C 40 1 ETC. Concentration of PG mucin in MQ-water was 40 mg/mL and concentration of 
alginate was 4.7 mg/mL. 
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Figure J-2. Elastic modulus (G’, left graph) and phase angle (δ, right graph) values for porcine gastric (PG) mucin control (saline) 
and PG mucin treated with alginate G-block DPn 12, alginate G-block DPn 24, alginate G-block DPn 33 and alginate LFR 5/60 
compared. All values are from frequency sweeps at 10 °C from low to high frequency with constant strain 1E-2 and 1E-2 Pa 
start stress. Cone dimension was C 40 1 ETC. Concentration of PG mucin in MQ-water was 40 mg/mL and concentration of 
alginate was 4.7 mg/mL. 
